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                                                     Introduction: 
Hearing is the special sense that enables us to recognize speech and other sounds(1). Ear 
is the earliest sensory organ to develop in the womb, and it gives us the capacity to hear 
and interpret sounds which is the basis for oral language, verbal communication, and 
interpersonal relationship, vocational and educational attainment. Although a child 
develops speech and language during the first three years of life, the ability to acquire 
effective spoken language is highest in the first six months after birth. (2)  
Hearing disorders may cause language impairment and slower cognitive, cultural, 
intellectual and social development(2). Hearing impairment in early stages of childhood 
would lead to speech and language defects which can restrict verbal communication 
with others. Thus, hearing loss should be detected at the earliest so that the language 
and social functioning may grow as normally as possible.(3) 
Various surveys indicate that prevalence rates of congenital hearing impairment is 
about1.2 to 5.7 per1000 live births(4). Congenital hearing impairment is seen between 
“1 and 3 out of every 1,000 children” (5). Of these, approximately 90% of newborns are 
born to parents who can hear(4)(6). 
Hence the ‘National Institutes of Health Consensus Development Conference on Early 
Identification of Hearing Impairment in Infants and Children’  recommends ‘a universal 
newborn screening’ for early identification of hearing impairment among the 
newborn.(6)  
Two methods are used in ‘universal newborn screening’ namely (1) Otoaccoustic 
emissions (OAE) and (2) Auditory Brain Stem Audiometry (ABR) both methods are 
automated. 
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Among these, MB11 BERAphone®, (a type of automated Auditory Brainstem Response 
test) which is objective screening tool,  has the added advantage of  detecting hearing 
defects such as auditory neuropathy (AN) which is not possible with  OAE testing.(7) 
However the manufacturer claims that the ‘BERAphone’ has a test “sensitivity greater 
than 0.99 and specificity of 0.87  for a single test and for a two-stage test the specificity 
is greater than 0.96, which is possible only when the test is performed in ideal conditions 
(8) 
Such a high sensitivity and specificity has not been the experience of the ENT 
department at CMC. This study was hence intended to determine the sensitivity and 
specificity of MB11 BERAphone®, in identifying neonates with congenital hearing loss in 
a post- natal ward setting. 
A two stage sequential screening with MB11 BERAphone® was done first in the postnatal 
ward and the second screening in the audiology room for all neonates born in the 
hospital, who fulfilled the inclusion criteria. Children ‘referred’ once were subjected to a 
repeat screening with ‘MB11 BERAphone®’ and compared with a confirmatory 
diagnostic testing with ABR (Auditory Brainstem responses) used as the Gold standard 
for confirming the hearing loss in neonates and infants. 
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AIMS & OBJECTIVES 
Objective 
The main objective of this study was to determine the reliability of MB11 BERAphone® 
as a screening tool in the postnatal ward setting. 
Aim  
1. To  calculate the sensitivity and specificity of MB11 BERAphone® when used as a 
screening tool as in identifying neonates with congenital hearing loss in comparison 
against the gold standard, Auditory Brain Stem response Audiometry (ABR) when 
performed at the bedside of the new born at the postnatal ward setting where the 
sound levels are over 35dB. 
2. To discuss the challenges of using the MB11 BERAphone® at the bedside in a ward 
setting for universal neonatal hearing screening.  
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REVIEW OF LITERATURE 
Hearing and communication      
“Communication is the key to the survival of life” (10). It is through various sensory 
organs that communication occurs. Effective communication takes place when the 
sensory organs function at their optimum level. 
Humans are equipped, in addition to highly specialized sensory organs like sight, 
hearing, taste, touch and smell,  with specialized skills of reasoning, analysis, assessment 
and communication through speech, writing and music.(11). Among the sensory organs, 
the sensation of hearing for speech and music is exclusively human(12). Therefore 
hearing is critical for expression through speech, language and music. (12) (13) 
Hearing an important sensory function 
The special sense of hearing develops in the womb before birth. Ear is the earliest 
intrauterine sensory organ to develop , and it gives us the capacity to hear and 
understand sounds which is the foundation for oral language, verbal communication, 
and interpersonal relationship, vocational and educational attainment(2). Hearing is 
important for development, since it connects with the rest of world and becomes an 
emotional link that contributes to mental and social health(14) . 
 Hearing impairment in early childhood would lead to lifelong speech and language 
defects which can restrict verbal communication with others(15) 
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Development of the Ear 
The development of the ear begins around the 22nd day of intra uterine life and is 
completed by 24 weeks(3).  
Studies have shown that the baby is able to hear sounds with a tone of 500 Hz as early 
as19- 26 weeks(3). Early sonograms show that foetuses in fact turn their head in 
response to the noise by 20th week and that hearing becomes established by the 3rd 
trimester(16)(17). 
Embryology of the ear 
The part of the ear that develops early is the membranous portion of the inner ear. A 
segment of thickened ectoderm over the hind-brain becomes gradually depressed 
forming the auditory placode and later into the auditory pit.(18). The mouth of the pit is 
then closed, forming the auditory vesicle (Fig. 1). 
                                                                                       
                                             Inner ear development                                               
FIG. 1– Grace Anatomy: Section through hind-brain showing the auditory pit and 
auditory vesicles of an embryo(18)    
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The auditory vesicle gets enclosed by the mesenchyme to form into the otic capsule. 
Diverticula develop from the otic vesicle forming the end lymphatic duct and sac. 
Another extension form the otic capsule gets coiled over itself to form the cochlear duct.  
     
FIG. 2- Grace Anatomy – Transverse section of the cochlear duct and membranous 
labyrinth(18) 
Three cavities within the duct which are the ‘scala vestibule’, the ‘scala tympani’ and the 
‘scala media’ are formed. The scala media contains the endolymph while the ‘scala 
vestibule’, the scala tympani contain an extracellular fluid called as perilymph (Fig 2). 
The vestibular and the basilar membranes divide the cochlear duct from the scala 
vestibule, the scala tympani. 
The cochlear duct is supported by a spiral ligament and a cartilaginous process as the 
modiolus which connects it to the cartilaginous structures around it. Later the sensory 
organ of hearing called the organ of Corti, which consists of the sensory cells and 
tectoral membrane is formed. 
The otic vesicle then forms the statoacoustic or the spiral ganglion. (18) 
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A group of sensory epithelium in the inner ear called the maculae acusticae develop over 
the saccule and utricle. 
 
FIG. 3 Grace Anatomy – Development of Semicircular canals (18) 
 Three ducts later develop forming the superior, lateral and posterior semicircular canals 
along with their sensory epithelium (Fig.3).     
The mesodermal tissue surrounding the labyrinth is converted into a cartilaginous ear-
capsule which becomes ossified to form the bony labyrinth.  A layer of mesodermal 
tissue becomes differentiated into three layers, namely the outer periosteal lining of the 
bony labyrinth, the inner layer in direct contact with the epithelial structures, and an 
intermediate gelatinous tissue.  The intermediate gelatinous tissue gets absorbed to 
form the perilymphatic spaces.  All these structures of the inner ear work together to 
convert the auditory signals received from the external and middle ears to electrical 
signals and finally convey them to the brain where they get analysed  (18). 
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Middle ear 
The middle ear and mastoid air cells develop from the endoderm of the tubotympanic 
recess which arises from the first and partly from the 2nd pharyngeal pouch. The 
Eustachian tube is the last structure of the middle ear which develops from the 1st 
pharyngeal pouch which connects the tympanic cavity and the nasopharynx. (18) 
The ossicles malleus and Incus develop from the mesoderm of the first pharyngeal 
pouch while the stapes develop from the second pharyngeal pouch which gets 
embedded in the tympanic cavity. The foot plate of the stapes and the annular ligament 
are derived from the otic capsule.  Finally, the tissue layer around the ossicles form a 
new endodermal layer of epithelial called the tympanic cavity wall. The mastoid process 
develops later as the tympanic cavity matures. (18) 
At 18 weeks the foetus is about 5.5 inches (140 mm) long and by this time bones in the 
middle ear develop and the nerve connections from the brain to the ear are formed. 
This enables the foetus to hear the mother’s heart beat and the flow of blood through 
the umbilical cord. (18) 
Malformation of the ear occurs because the embryologic source and the development of 
the inner ear are independent of the timing and the development of the middle and 
external ear. (18) 
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External Ear 
By the 6th week of foetal life, a series of six tubercles appear around the 1st branchial 
cleft which progressively coalesces to form the auricle. Tragus develops from the 
tubercle of the first arch, while the rest of the pinna develops from the tubercles of the 
second arch and achieve the adult shape by the 20th week of foetal life. (18) 
The external auditory canal develops from the dorsal portion of the 1st pharyngeal arch.  
The tympanic membrane along with three layers, the outer epithelial, middle fibrous 
and the inner mucosal layer develops from the three germinal layers namely the 
ectoderm, endoderm and mesoderm. (18) 
Initially the external ears are placed in the lower part of the neck region. When the 
mandible develops they then migrate upwards to their final location in level with the 
eyes. Once they are fully formed, the external ear helps in capturing the sound from the 
outside and then conduct it through the external auditory canal and then toward the 
tympanic membrane. (18) 
Molecular Regulation of the Inner Ear 
Molecular Regulation of the Inner Ear occurs through a set of genes called the “home 
box gene family” such as “Pax”, “Msx” and “Otx homeobox genes”.  
 The maturity of the Cochlea is regulated by several genes like” Dlx5/Dlx6”, “Otx1/Otx2 
and Pax2”, which are influenced by the master gene “Shh” produced by the notochord. 
(19) 
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Physiology of sound production 
The Physiology of hearing 
Hearing is the process where the ear converts the sound vibrations present in the 
surroundings into nerve impulses which are then sent to the brain, where they are 
understood as sounds.(20) The human ear is most sensitive to sound frequencies 
between 1,000 to 4,000 hertz. The range of human hearing is between 0 dB, which is 
just inaudible, to about 130 dB at which measurement the sound becomes painful(21) 
For a sound to be conveyed to the central nervous system, the energy of the sound must 
pass through three stages. 1) The vibrations pass through the tympanic membrane and 
the ossicles of the middle ear. 2) Vibrations pass through the inner ear fluid within the 
cochlea. 3) These travelling waves across the basilar membrane excite the hair cells in 
the organ of Corti where they are changed to nerve impulses in the cochlear nerve.  
They are then transmitted to the brain stem, and finally relayed to the ‘primary auditory 
area’ of the cerebral cortex, which is the centre of the brain for hearing. Only after the 
nerve stimulus arrive at this area, the listener becomes aware of the sound.(20)  
Sound waves transmission of through the outer and middle ear 
The auricle collects sound waves and funnel sound into the external auditory canal 
which helps to amplify the sound that reaches the tympanic membrane like a resonator 
adding 10-12 dB to this frequency.(22) Thus it increases the sound pressure at the drum 
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and helps in localizing the direction of the sound.  The shape of the auricle facilitates in 
filtering out the unwanted frequency above 6 kHz and help in sound discrimination.(22)  
At the tympanic membrane some sounds are absorbed and some are reflected. The 
absorbed sound waves enter the umbo, causing an inward and outward bending which 
gets the membrane in motion. The deflection of the membrane is greater when the 
sound is louder, and movement is faster when the pitch of the sound is higher. These 
movements are then shifted to the handle of Malleus and then to the other ossicles(20).  
The vibrations then cause the stapes to rock back and forth at the lower pole of its foot 
plate thus the sound waves are transmitted to the perilymph of the vestibule and to the 
scala vestibule(20). 
Function of the ossicular chain 
When sound is transmitted from the external to the inner ear, the vibrations of the air 
must be converted to vibrations in the cochlear fluids which would cause resistance to 
the passage of sound called as the ‘impedance’(20) .  Due to the ‘impedance mismatch’ 
between air and inner ear fluids, about99.9% (~30–35dB) of the acoustic energy in aerial 
signals would be lost or reflected. Middle ear compensates for the impedance mismatch, 
through impedance matching (acoustic transformer) by 1) Hydraulic action of the 
tympanic membrane 2) Lever action of the ossicles 3) Curved membrane effect (20). 
The effective areal ratio between the tympanic membrane and the stapes foot plate is 
14:1 and in the ossicular chain the handle of malleus id 1.3 times longer than the long 
process if incus which provides a mechanical advantage of 1.3.  
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Thus the product of areal ratio and lever action of ossicles is 18:1. In this way the middle 
ear converts sound of ‘lesser amplitude but greater force’ to ‘greater amplitude but 
lesser force’ which help in the transmission of sound.(20)  
Function of the middle ear muscles. 
Contraction of the muscle ‘tensor tympani’ pulls the handle of the malleus inward and 
thus tenses the tympanic membrane to various sounds.  
Tensor tympani and stapedius muscles help to decrease a person’s hearing sensitivity to 
his or her own speech by the contraction of the stapedius and thus reduce the intensity 
of sound reaching the cochlea. The stapedius muscle in addition responds reflexly to 
sounds of high intensity frequencies below 1000cycles per second  of the same ear 
or the opposite ear protecting from frequencies that damage the ear, similar to the blink 
of the eye (20) 
Thus the middle ear helps in i)impedance matching, ii) physically protects the cochlea 
and provides iii) a preferential path way for sound transmission (20). 
Sound transmission in the inner ear 
Once the sound waves by the vibrations of the stapes foot plate reach the oval window, 
the pressure waves are set up in the perilymph of the scala vestibuli present in the 
cochlea. The sound vibrations are then transmitted to the endolymph by the movement 
of the basilar membrane inside the cochlear duct which cause the organ or Corti move 
against the tectoral membrane.  
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The cochlea then analyzes the different frequencies of complex sounds by means of the 
movement of the basilar membrane, due to different amount of stiffness, or along the 
entire length. Inside the cochlea the vibrations are then converted into the electrical 
impulses which are sent to the brain stem by the cochlear nerve.(20).  
Transduction of mechanical vibrations 
The endolymph contains a high percentage of potassium level that causes a positive 
potential in the cochlear duct which surrounds the top of the hair cells. The perilymph 
on the contrary has a low potassium level and a negative potential in the scala vestibuli. 
Thus a potential difference of +80 millivolts due to the difference in potassium between 
the endolymph and perilymph called the endocochlear potential which is there between 
the endolymph and the perilymph. The inside of the hair calls has a negative intracellular 
potential of -60 millivolts in relation to the perilymph and -140 millivolts in comparison 
to the endolymph. This steep gradient which is present at the tip of the cell is known to 
stimulate the cell to the least sound vibration. (20). 
Transduction of Mechanical Energy to Electrical Impulses  
Movements of the stapes footplate are transmitted to the cochlear fluids which move 
the basilar membrane, setting up shearing force between the tectorial membrane and 
the hair cells. This distortion of hair cells, gives rise to cochlear microphonics which 
triggers the nerve impulse.  The neurotransmitters are taken up by the nerve fibres 
which are located at the basal end of the hair cells, thus exciting them into sending an 
electrical signal across the entire length of the cochlear nerve.(22)   
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Greater frequency sounds are localised in the basal turn which progressively decrease 
towards the apex. A sound wave, reaches maximum amplitude on a ‘particular place’ on 
the basilar membrane and stimulates that segment, thus the sound wave is generated 
and transmitted along the cochlear nerve [travelling wave theory of von Bekesy] (20) 
Cochlear nerve auditory pathways 
Hair cell gets its innervation from the bipolar cells of spiral ganglion. Central axons of 
these cells collect together, to form the cochlear nerves which end in the ventral and 
dorsal cochlear nuclei. From there, both crossed and uncrossed fibres travel to the 
superior olivary nucleus, the lateral lemniscus, inferior colliculus, and medial geniculate 
body which reach the auditory cortex of the temporal lobe. (20). 
Auditory nerve fibres 
The vestibulocochlear nerve or the eighth nerve has two anatomically different and 
functionally separate parts namely a) the cochlear nerve, which is connected to the 
organ of hearing, and b) the vestibular nerve which in turn is connected to the organ of 
equilibrium. Fibres from the cochlear nerve take their origin from the cell bodies of the 
bipolar nerve of the spiral ganglion which is present in the modiolus of the cochlea. The 
central longer fibres, called as the “primary auditory fibres” form the cochlear nerve. 
Whereas, the shorter unmyelinated peripheral nerves go on to innervate bases of the 
inner and outer cells.(20).There are only 30,000 of these unmyelinated peripheral nerve 
fibres.  
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Out of these 95 percent of them innervate the inner hair cells, while the remaining pass 
through the tunnel of Corti to connect to the outer hair cells. The central process of the 
bipolar cochlear nerves called primary auditory fibres  form the cochlear nerve trunk 
which come out from the modiolus through the internal auditory meatus and then 
immediately pass into the brain stem of the medulla (20). 
Ascending pathways 
The central auditory pathways consist of a series of nuclei that extend from the medulla 
to the cerebral cortex. The cochlear nerve terminates in the medulla where they reach 
the cochlear nucleus which is separated into dorsal and ventral cochlear nucleus(20).Fig 
6. Each of the cochlear nerve fibre sends one of its branch to the dorsal and other 
branch to the ventral cochlear nucleus. From there, both the crossed and uncrossed 
fibres travel to the superior olivary nucleus and lateral lemniscus. This major tract called 
as the lemniscus is where most of these fibres end up in the inferior colliculus, which is 
the “auditory centre of the midbrain”. Some of the fibres may go around the colliculus 
and end at the next highest level which is the ‘medial geniculate body’. The fibres are 
projected to the cortex of the temporal lobe from the medial geniculate body(20). 
Descending pathways 
There is a descending pathway from the cortex to the cochlear nuclei which is parallel to 
the ascending pathway that goes from the cochlear nuclei to the cortex. In both the 
ascending and descending pathways some of the fibres stay on the same side, while 
some go along the midline towards the opposite side of the brain. In general, the 
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descending fibres exercise an inhibitory function by means of ‘negative feedback’ 
mechanism.  
At the lower level of this pathway, the information with regard to the loudness, pitch, 
and localization of sounds is analyzed and proper response such as; the contraction of 
the middle ear muscles or the turning of the eyes and head or the body movements take 
place as a whole. (22) 
  
Fig-4a.Guyton- Auditory pathway(18)            Fig-4b.Guyton- Primary and secondary 
auditory cortex (18) 
In humans beings the ‘primary auditory cortex’ lie mostly on the supratemporal plane of 
the ‘superior temporal ‘gyri of Heschl’ and also go into the lateral side of the temporal 
lobe present on the lower lobe of the deep gap between the temporal and parietal lobes 
along the sylvian fissure called as the  ‘secondary auditory cortex’(20).Fig 4b  
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The projections from the medial geniculate body cause direct excitation of the ‘primary 
auditory cortex’ where as the ‘auditory association areas’ get stimulated secondarily by 
the impulses from the primary auditory cortex along with  some projections from the 
‘thalamic association areas’ present next to medial geniculate body(20). Thus the central 
function of the auditory cortex is ‘sound localization’, ‘lateralization through auditory 
discrimination’, ‘temporal resolution’, ‘masking’, ‘integration and ordering’. (20). 
For each ear, both the right and left cerebral cortex is represented bilaterally. About half 
of the fibres of the auditory pathways cross the midline while the others go up on the 
same side of the brain. Due to this reason, even when the auditory cortical area on one 
side is injured by trauma or stroke binaural hearing may not be adversely affected. (20).  
Maturity of auditory pathway & Plasticity 
Maturity of the neurological auditory system occurs in two stages. The first phase is 
‘intrauterine stage’ which is completed by the sixth month of gestation. At this time the 
peripheral auditory pathways are established and mature. The second phase starts ‘after 
birth’ and id completed around 18 months of life. By then the auditory pathways up to 
the brainstem reach maturity. (23) 
The ‘maturation’ of the auditory pathway can be assessed, by calculating the ‘pontine 
auditory conduction velocity’ (PACV) which is obtained by studying the auditory 
brainstem response (ABR) along with the magnetic resonance imaging, which is a precise 
indicator of the auditory function (13). To assess the brainstem function more 
accurately, PACV in individual patients can be used.  
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The results show that during the third trimester and in the first two years of life, the 
‘peak latencies of ABR’ and ‘I-V interpeak latencies’ which are indicative of the delay in 
central transmission are gradually reduced. Marked development during the above 
mentioned time period is seen in the calculated ‘pontine auditory conduction velocity’ 
(PACV).  By the age of two to four years, the PACV value almost equal to that of the 
adults. (13)  
The thickness of nerve cells in the inferior colliculus and in the cochlear nucleus was 
found to reduce with age through a ‘histomorpho-metrical’ study. The study also 
showed that from the late fetal to the infantile period there was an increase in the 
myelination of the lateral lemniscus. Mostly in the infantile period, the myelin sheaths of 
the large diameter nerve fibre showed increase. Studying ABR in combination with the, 
‘quantitative histomorphometrical investigation’, showed that the increase of PACV was 
seen to be related to the maturation of nerve cells in the upper nuclei which was 
corresponded  to the myelination of the small and large fibres of the auditory 
pathway.(24) 
Plasticity & auditory deprivation 
“Plasticity  is a property of the nervous system to modify of change itself as a result of 
sensory experience(25)  “Neuroplasticity” or Plasticity or refers to the “alterations in the 
physiological and anatomical properties of neurones in the brain in association with 
sensory stimulation and deprivation (25)  
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Neuroplasticity is seen to be more marked during infancy, since the neural architecture 
is being established during this time. The other area where plasticity is seen is in 
developing sound localisation. To the differences in the sound intensities, a map of 
‘auditory space’ is generated and the arrival time between the two ears is represented in 
the superior colliculus. This map is known to be very  plastic during 
development.(13)(23)  
The present research shows that during deafness, the normal auditory development is 
arrested and disrupted leading to several changes in the auditory pathways which occur 
during the period of deafness. The extent and the type and of change that occur in the 
auditory pathway is dependent on the following factors such as 1) the age of deafness, 
2) the stage of deafness 3) the auditory development at the onset of deafness, 4) the 
type and the cause of deafness, 3) and the duration of time the immature auditory 
pathways are left without a large auditory input or stimulus. Due to sound deprivation 
there is an arrest in the development of the auditory brainstem and the thalamo-cortical 
areas due to which other ‘competitive areas’ like vision can take over. (25) 
The sensitive period, in the absence of normal stimulation, during which the central 
auditory system remains highly plastic is about 3.5 years. In some children plasticity 
remain until approximately 7years of age after which it is greatly reduced.(25)  
Although some studies done by Shepard, Heid, & Klinke, 1997 have shown that in the 
absence of sound, the functional nerve connections in central auditory system is 
established. 
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 In 1999, Hardie, & Shepherd proposed that the auditory deprivation causes wide-spread 
degeneration in the central auditory system which result in the following changes: (13) 
a. Reduction in the cell density of the spiral ganglion and anteroventral and ventral part 
of cochlear nucleus. 
b. Changes in the neural projections between brainstem nuclei. 
c. Decreased cortical synaptic activity in cortico-cortical and cortico-thalamic 
connections.  
d. Reduced number of primary dendrites in cortical pyramidal cells. 
e. Takeover of auditory cortical areas by visual function”. (13) 
Sounds in the womb 
Studies done by placing tiny microphones in the uterus near the foetus' head show that 
sound level in the womb is around 75 dB. Fifer and Moon et al showed that newborns 
prefer the sound of their mother’s voice which is transmitted through the various 
vibrations through her body (26) 
By 25 weeks the baby is able to recognize different voices. Through the use of high 
sonograms and high tech tools, researchers have found that the foetus live in an 
auditory playground, responding to voices outside the womb.(26) Studies show  that 
foetus has a highly developed hearing mechanism which has the auditory preference to 
certain sounds like native language and music in the womb (27)(28).  
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Preterm and hearing sensitivity 
Research has shown that the sensation of hearing is so delicate especially in the preterm 
child that the loud noise in the NICU can affect their hearing.  The auditory system of the 
preterm is in a critical period of neurodevelopment after birth and they are no longer 
protected by the maternal womb to loud noises. This sudden transition from the womb 
exposes them to the ambient noises present in the care units which can disrupts their 
growth and development(16)  
Studies done by Erin McMahon and et al  suggest that the exposure to noise outside the 
womb by the preterm babies can put them at risk for hearing, language, and cognitive 
disabilities.(3) 
Hearing evaluation of the ‘small for date’ new born babies showed a considerable delay 
in the emergence of waves III and V, and delay in waves’ I-V of ABR testing, which 
suggests that an auditory pathway alteration within the brainstem  rather than an 
impairment of the peripheral auditory apparatus has occurred. (29) 
All the above mentioned studies show that hearing is one of the very first sensory 
organs to develop and that this development involves complex mechanisms that are 
essential to the development of speech and language outside the womb. Further, that 
the conditions surrounding the infant after birth can influence the speech, hearing and 
communication.(2) 
 
22 
 
Hearing and development of language 
Hearing and speech and are strongly inter-related. Our ability to communicate through 
speech with others is dependent on our capability to hear. Therefore, in the 
development of speech and language, hearing ability has a strong part. 
 “language” by definition,  is the formulation and understanding of communication using 
words”, and speech is the “physical act of producing the words that convey linguistic 
ideas”(30). This is a special and unique capability present among humans which should 
be cultivated and preserved. The ability to speak various languages and sounds is 
developed and cultivated throughout life. It  is dependent on i) hearing others speak in 
order to observe and register the pattern of accurate pronunciation of sounds and 
words, and learn to differentiate between the various type of sounds. b) the ability to 
hear one’s own speech is called as the "auditory feedback loop." This special ability helps 
to monitor the individual’s speech and allow for refining or modifying the speech 
production. 
Articulation is also essential in order to speak properly. In order to produce the different 
type of voice coming from the larynx, the anatomical structures in the oral cavity are 
made to synchronize together into the various sounds that form the words that we 
speak. (31) 
Because of an incomplete ‘auditory feedback loop’ that lead to ‘imprecise articulation 
and substitution errors’, those with hearing impairment, will not be able to perceive the 
sounds clearly eg: "f" for "th".  
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There is an overall misrepresentation of speech due to imperfect sound awareness. 
Problems with articulation lead to decreased "speech  intelligibility," of  the speaker 
which is understood by a listener (32) 
According to the American Speech-Language-Hearing Association, children with listening 
difficulties would have difficulty with grammatical structures, vocabulary, multiple 
meaning words, plural word endings and abstract words due to hearing loss (33) 
In four major ways, hearing loss affects children; it causes 1) delay in the development of 
“receptive and expressive communication skills like speech and language, 2) Cause 
learning problems and language deficit that would result in lower academic 
achievement. 3) Social isolation due to communication difficulties which would lead to 
poor self-concept and 4) Inability to learn vocational skills which would in turn impact 
vocational choices (34) 
Hearing disorders as seen above, result in slower intellectual, cognitive, language, 
cultural and social development.  Hearing is therefore paramount for development of 
the child because it provides an opportunity for individual incorporation into a society 
where the oral communication predominates.  
Hearing impairment is truly a crippling impediment that has been expressed by persons 
who were affected by it. Hellen Keller who had lost both her sight and hearing at a very 
early age expressed that “while blindness separated her from things, her disability of 
speech and hearing had separated her from people and from communication (35) Such 
is the effect of hearing impairment on a person’s psycho-social wellbeing.  
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Hearing loss not only handicaps a person at a personal level, it actually isolates the 
individual by impeding with communication and expression. 
Critical period for speech and language development 
The significant phase for speech and language development is around the time from 
birth to about five years, the lack of early auditory stimulation during this critical 
language-learning years makes it difficult for the attainment of speech and language 
skills at a later time.(36)  
Data from cohort studies indicate that the crucial time for the diagnosis and intervention 
is earlier than six months of age, since it provides opportunity for the improvement of 
language and speech in hearing-impaired children(37). Studies also have shown that 
those infants who have been identified and rehabilitated below six months fared better 
in their language, skills than the ones done after six months. (37)(2). In order for the 
language and social functioning to develop as normally as possible, hearing loss should 
be detected as early as possible.(3). Delay in the identification and rehabilitation would 
lead to marked delay in the language quotient (LQ) and cognitive quotient (CQ) which 
hinder the overall development of the child.  
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Figure 5: Discrepancy between language quotient (LQ) and cognitive quotient (CQ) of 
children with hearing loss before and after 6 months (Paediatrics, vol 102, p 1161–1171). 
Currently detection of significant hearing loss occurs around the age of 14 months. This 
underscores the urgency in early identification and intervention of hearing loss by six 
months since it  provides opportunity for better prospects in language development, 
academic success, social integration in the society.(37) 
Hearing loss - Definition 
According to Mosby's Medical Dictionary, hearing loss is “an inability to perceive the 
normal range of sounds audible to an individual with normal hearing” or any degree of 
impairment of the ability to apprehend sound. (38)(39) 
Hearing loss is not the same for everyone and therefore the different degrees of hearing 
loss are divided into categories.  One of the commonly used classifications is given by 
the “American Speech-Language-Hearing Association (ASHA). The table below shows the 
classification as per the degrees of hearing loss or the severity of hearing loss(40) 
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Degree of hearing loss Hearing loss range (db HL) 
Normal -10 to 15 
slight 16 to 25 
Mild 26 to 40 
Moderate 41 to 55 
Moderately severe 56 to 70 
severe 71 to 90 
Profound 91+ 
Table 1  Source: Clark, J. G. (1981). Classification of hearing loss, as given by “American 
Speech-Language- Hearing Association (ASHA). Hearing loss range in decibels (dB HL) 
Any hearing loss must be quantified on the basis of degree of hearing impairment, the 
‘type’ of hearing loss and the ‘percentage’ of hearing impairment 
WHO grading of the degree of hearing loss is given below 
WHO grades of 
hearing loss    
Audiometric ISO value  
Impairment description         
(average of 500, 1000, 2000, and 4000 
Hz)  
0 (no impairment)                                  25 dBL or less (better 
ear)            
No or very slight hearing loss 
1 (slight impairment)                              26 - 40 dBHL (better 
ear)                 
Able to hear whispers. Able to hear and 
repeat words spoken in normal voice at 
1 meter.                                                                                                                                        
2(Moderate 
impairment) 
41-60  dBHL (better 
ear)                 
Able to hear using raised voice at 1 
metre and repeat words  
3 (severe 
impairment) 
61-80 dBHL (better ear)                  Can hear some words when shouted             
4(profound 
impairment                       
    including 
deafness)                                                                                          
81 dBHL or 
greater(better ear)       
Not able to hear and understand even a 
shouted voice.       
Table-2 : WHO grading or degree of hearing loss(41) 
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Types of hearing loss 
According to the European working group on genetics of hearing , the types of hearing 
impairment can be classified as follows(42) 
                                                                            Types of hearing impairment 
Conductive hearing 
impairment: 
 
Related to disease or deformity in the outer or middle ears. 
Audiometrically bone conduction thresholds(< 20 dB) and 
an A-B gap >15 dBHL averages over 0.5,1.0 and 2 HZ 
Sensorineural  hearing 
impairment: 
Disease or deformity of the inner ear or cochlear nerve with 
an air/bone gap < 15dB averaged over 0.5, 1 and 2 kHz. 
 Sensory: sensorineural subdivision of related to a disease or 
deformity in the cochlear nerve 
Neural::- sensorineural subdivision of related to a disease or 
deformity in the cochlear nerve 
Central: sensorineural subdivision of related to a disease or 
deformity in the cochlear nerve 
Mixed hearing 
impairment: 
 
Combined involvement of the outer or middle ear and the 
inner or cochlear nerve. Audiometrically >20dBHL in the 
bone conduction threshold together with > 15 dB A-B gap 
averaged over 0.5, 1 and 2 kHz(42)  
Table – 3 : European working group on genetics of hearing types of hearing loss (43)  
Expanded criterion of hearing loss 
The American academy of Paediatrics in their official joint position statement -2007 had 
made an addition to the classification of hearing impairment.   
From congenital permanent sensory hearing loss or permanent conductive hearing loss, 
the definition of hearing impairment has been expanded to include ‘neural hearing loss’ 
which includes auditory neuropathy or dyssynchrony in infants admitted to the 
NICU.(39) 
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Hearing impairment percentage  
In order to calculate the percent of hearing impairment according to the journal of 
American medical association,  25 dB is subtracted from pure tone average of 500 Hz, 
1000 Hz, 2000 Hz, and 3000 Hz and the result obtained is multiplied by 1.5 to give an 
‘ear sporadic level’. The impairment is determined by weighing the better ear five times 
the poorer ear (44). 
It may be misleading to calculate the functional impairment based on just the pure tone 
and may not be very useful because the conversational speech is at around 50-60 dBHL. 
Therefore a hearing loss of 45-dB is functionally more significant than a mere 30%.  
Hence a different scale of rating young children with limited hearing loss is needed, 
which would have a significant impact on language development(44) (8) 
 % 
Impairment 
Pure Tone Average (dB)  
% Residual Hearing 
100% 91 dB 0% 
80% 78 dB 20% 
60% 65 dB 40% 
30% 45 dB 70% 
Table 4- pure tone average of 500 Hz, 1000 Hz, 2000 Hz, and 3000 Hz Percent Hearing 
Impairment for young children (44) 
Once the hearing loss assessment is made the cause of congenital hearing impairment is 
to be found out. 
It has been found that 3 in every 1000 newborns have significant hearing loss which can 
be caused by illness or injury which occurs after birth or inherited (congenital).(45) 
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Etiopathogenesis of congenital hearing loss 
Maldevelopment of the inner ear occur between the third and seventh week of 
intrauterine life when the auditory placodes and the membranous labyrinth 
differentiation take place.(46).  
Several morphological congenital abnormalities of the inner ear occur such as 
maldevelopment of the bony labyrinth, the membranous labyrinth, receptor organs and 
their supporting cells occur due to which severe sensory neural hearing loss occurs. (46) 
Inner ear sensory hair cells are essential for hearing. Scientists believe that hearing 
impairment occur as a result of mutations in as many as 400 genes(47).  These 
mutations in the cells can result in improper functioning leading to hearing loss. These 
gene mutations may contribute to several hereditary  or non-hearing related, conditions 
along with deformation of the inner ear, that can result in deafness at birth or later in 
life.(48)  
About 50% of cases on non-syndromic genetic hearing  is caused by a mutation in a gene 
called as “connexin 26”(49).One third of severe-to-profound congenital deafness and 
half of profound autosomal recessive non-syndromic hearing loss (ARNSHL) are caused 
by mutations in “Connexin 26 and GJB2”, (a gene that encodes a ‘gap junction 
protein)(44)  
A common congenital viral infection like Cytomegalovirus (CMV) is associated with 
congenital hearing loss due to changes that occur in the stria vascularis, cochlear 
duct and saccular hydrops. (44)(46) 
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Prevalence of congenital hearing loss 
Various surveys have reported the prevalence rates for bilateral congenital hearing 
impairment to be 1.2 to 5.7 per 1000 live births (2). According to the American Academy 
of Paediatrics task force report on newborn and infant hearing, 2 to 4 per 100 infants in 
the intensive care unit, and 1-3 per 1000 newborn infants in the well-baby nursery 
population have considerable bilateral hearing impairment.(45)(51)(50)  
Several studies show that for bilateral hearing loss of more than 35 dB, the prevalence of 
hearing loss in the new born population vary from 0.9 in 1000 to 3.24 in 1000, and 5.95 
in 1000 for unilateral and moderate hearing loss(51). 
 
Figure 6: Prevalence rate of B/L Hearing loss (7) 
The current situation in India is that 4 in 1000 children born were found with severe, to 
profound hearing loss(52)(53).  
Prevalence rates ranging from 1% to as high as 40% were seen in studies conducted in 
2004.  
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The Indian Council of Medical Research reported that the incidence of conductive 
hearing impairment in 1983 had been 48% in rural areas. In 1991, the National Sample 
Survey Organisation (NSSO) reports of 1986 showed 3.02 million deaf population in India 
and 3.24 million in the age group of 5-14 years (52) 
The prevalence of hearing disability in India according to the National Sample Survey 
showed that  5.53 per 1000 in rural and 3.90 per 1000 in urban areas(52). According to 
Parmod Kalsotra et al hearing impairment affects 1.8% of the population in India (9). 
In every 1000 births, about 10 new borns are estimated to be affected by a severe to 
profound hearing loss in developing countries. Of the 62 million deaf children younger 
than 15 years, two-thirds, live in developing countries worldwide(55). According to  
WHO estimates in 1998,two-thirds of 123 million people in the world with a hearing loss 
of 41dB or more live in Asia.(52)  
About 0.3 million between 0-4 years of age group and 1.5 million in the age group of 5-
12 years had hearing impairment, according to the Human Development report of 
1999(4). 
Paul et al suggests that 1 to 3 per 1000 new born infants in the nursery had congenital 
bilateral hearing loss.(45) 
Of these, the unexpected feature is that approximately 90% of these children with 
deafness were born to parents not having hearing problems [5]. More  than 50% of 
hearing loss in children is genetic and not related to anatomic, infectious, or other non-
inherited causes. [6].  
32 
 
Causes of congenital hearing loss(56) 
The causes of hearing loss can be broadly divided as i) Prenatal and ii) Post natal causes.  
5-10 percent of congenital hearing loss seen at birth is due to prenatal illnesses. Of these 
50% of congenital hearing loss is due to genetic causes and the other 50% is due to 
environmental causes.   
It can be further classified as idiopathic and non-genetic types. (7)  
i) Prenatal causes 5-10% 
Idiopathic cause (25%): The idiopathic cause accounts for about 25% of hearing loss.  
Non-genetic factors ( 25%): 25% of hearing loss is due to non genetic factors such as 
maternal infections,( rubella, cytomegalovirus, herpes simplex virus, or German 
measles), Toxins, drugs and alcohol during pregnancy, maternal diabetes, toxaemia 
during pregnancy , prematurity, low birth  weight, birth injuries, Rh factor 
incompatibility, jaundice, cause hearing loss(9) 
Genetic factors (50%): More than 50 percent of all hearing loss is caused by hereditary 
or genetic factors. These genetic defects present at birth or develop at a later period. 
Rare types of genetic hearing loss can be due to mitochondrial inheritance patterns or is  
X-linked (related to the sex chromosome). (56) 
The genetic factors causing hearing loss can be further classified as a) non-syndromic  
congenital hearing loss b) Syndromic congenital hearing loss.  
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Syndromic hearing impairment occurs along with a specific group of birth defects and 
the non-syndromic hearing impairment can be either autosomal recessive or autosomal 
dominant and implies that this could be the only birth defect the baby has.  
In autosomal recessive hearing loss, both parents even without a hearing loss, carry 
recessive gene and transfer it on to the child. Since they are unaware that they carry a 
defective gene, the parents may be surprised to see their child with a hearing loss. This 
type of inheritance cause 70% of all genetic hearing loss (9) 
The autosomal dominant hearing loss  is about 15% of all genetic hearing loss  which is  
due to an abnormal gene from either of the parent, even though the matching gene of 
the other parents’ being normal. The parent with the dominant gene may have a hearing 
loss along with other signs and symptoms of that genetic syndrome.  
Several genetic syndromes have hearing loss as one of their symptoms like Down 
syndrome, Usher syndrome, Treacher Collins syndrome, Alport syndrome, and 
Waardenburg (9)   
ii) Postnatal Causes of hearing loss (10-20%) 
Postnatal causes account for 10-20% of hearing impairment which can be temporary or 
permanent. Permanent hearing loss can be caused by Head injury, childhood infections, 
like measles or chicken pox, meningitis. Temporary hearing loss is caused by medications 
like amino glycosides, ear infections like otitis media which can cause a permanent 
hearing impairment(56)  
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According to a study done at All India Institute of Medical Sciences (AIMS) in 2002 ,the 
most common cause of prenatal group of hearing loss according to Parmod Kalsotra et 
al, was due to maternal Rubella. Perinatal causes of hearing loss were birth anoxia and 
prematurity while postnatally, meningitis was most common aetiology of hearing 
loss.(57)  
Risk factors for neonatal sensorineural hearing loss 
The “American Academy of Paediatrics Joint Committee on Infant Hearing Year 2007 
Position Statement” has outlined the risk factors associated with congenital hearing 
loss.(39) These are 1)Hearing, speech, language, and developmental delay, 2) Family 
history of permanent childhood hearing loss  3)Neonatal intensive care of more than 5 
days or 4) any of the following regardless of length of stay such as assisted ventilation, 
exposure to ototoxic medications (gentamicin and tobramycin) or loop diuretics like 
furosemide(Lasix), and hyperbilirubinemia that requires exchange transfusion. In utero 
infections such as CMV herpes, rubella, syphilis, and toxoplasmosis. Craniofacial 
anomalies, including those that involve the pinna, ear canal, ear tags, ear pits and 
temporal bone anomalies. Physical findings such as white forelock are known to be 
associated with sensorineural or permanent conductive hearing loss.  
Other Syndromes associated with hearing loss or progressive or late-onset hearing loss, 
such as Neurofibromatosis, osteopetrosis, and Usher syndrome and other frequently 
identified syndromes like Waardenburg, Alport, Pendred, and Jervell and Lange-Nielson.  
Neurodegenerative disorders, such as Hunter syndrome, or sensory motor neuropathies, 
like Friedreich ataxia and Charcot-Marie-Tooth syndrome.  
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Culture-positive postnatal infections associated with sensorineural hearing loss, 
including confirmed bacterial and viral (especially herpes viruses and varicella) 
meningitis. Head trauma, especially basal skull/temporal bone fracture that requires 
hospitalization. Recurrent or persistent otitis media for at least 3 months. (39) 
In order for any of the condition to be identified as congenital or hereditary the 
European Working Group on Genetics of Hearing Impairment had outlined the exclusion 
criterion which is given below(42). ‘Genetic cause’ on family history should be 
substantiated and hearing impairment should be considered as ‘famillal’or‘inheritance’ if 
a. “One or both parents or grandparents affected for two or more generations. 
b. Pedigree that suggests inheritance. 
c. Two or more children affected with unaffected parents. 
d. Consanguinity to any degree. 
e. Only child with unaffected parents but with affected cousin(s). 
f. Pedigree indicating X-linked inheritance. 
g. Pedigree indicating mitochondrial inheritance. 
h. If there is any recognised syndrome” 
Clinical audiological "hereditary" hearing impairment is a diagnosis made on probability 
where the clinician and the geneticist should base their assessment from the assessment 
made. 
Early Identification of Hearing Impairment  
According to U.S. Surgeon General, Dr. C. Everett Koop, M.D., ‘‘Because it interferes with 
the development of language, deafness in infants is a serious concern since it sets 
humans apart from all other living things”(58) 
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In order to minimize the harmful effects according to the American Academy of 
Audiology, on speech, language, education, and psychological, social development, early 
identification, assessment and intervention for all types of hearing impairment in 
neonates and younger should be done (59) Lifelong defects in speech and language 
development, personal-social maladjustments, poor academic performance and 
emotional difficulties, occur when there is failure  in early detection of children with 
congenital or acquired hearing loss. Early recognition of hearing loss, on the contrary,  
with appropriate involvement within the first 6 months of life have shown allay many of 
these adverse consequences.(60) 
Primary mode of detecting hearing loss 
It has been found that in almost two thirds of cases the usual primary mode of detecting 
hearing loss in children is by the parents themselves where the  parents are the first 
ones to identify hearing loss, as observed from the child’s inadequate or lack of response 
to sound. This passive detection method usually occurs at a mean age of 22 months by 
which time, there is considerable delay in early diagnosis and auditory rehabilitation of 
the child. (61). Usually the other health care providers pick up the hearing loss only in 
approximately 15% of cases, and paediatricians in roughly 10% of cases.(62) 
The child’s speech, language and cognitive development would be severely impaired, If 
congenital hearing loss is not detected early and managed.(63) Giving attention to the 
child’s responses and general behaviour along with early hearing screening is therefore 
important for early detection and rehabilitation.  
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Various surveys indicate that prevalence rates of congenital hearing loss are 1.2 to 5.7 
per 1000 live births. Of these, approximately 90% of children with hearing loss have 
parents without hearing problems. Hence the National Institutes of Health Consensus 
Development Conference on Early Identification of Hearing Impairment in Infants and 
Children recommends a universal newborn screening for early identification of hearing 
loss among the infants.  
In a longitudinal study of 10 years, it has been reported that with immediate audiological 
and family centred programmes on children with hearing loss between 0-6 months, 
significant higher developmental function have been achieved in relation to increased 
expressive vocabulary and language than those with delayed identification, and 
rehabilitation(45)(2). 
These studies underscore the importance that  early identification and intervention for 
hearing loss by six months would provides better opportunity for language 
development, academic success, and social integration into the society. (45) 
Evidence is  shown in the Joint Committee on Infant Hearing’s Year 2000 Position 
Statement, Principles and Guidelines for Early Hearing Detection and Intervention 
Programs, which was endorsed by the “American Academy of Paediatrics (AAP)(64). This 
confirmation is the reason which resulted in effective universal hearing screening 
program. (65) 
Because 50 percent of congenital hearing loss is genetic, the ‘genetic services’ should 
also be a part the newborn hearing screening and Early detection and Hearing 
Intervention (EHDI) Programs. 
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If they undergo genetic tests and counselling along with the screening programmes, 
significant benefits for children with hearing loss and their families are seen.(8)  
Although, Ewing had endorsed importance of early identification of hearing loss in 
addition, its usefulness was known for almost 60 years;  yet implementation  of the 
screening programme during the first few months of infants did not materialize until 
1980’s till the development of accurate, inexpensive, and practical screening 
equipment.(8). Hearing loss in infancy without appropriate tools for screening can be 
difficult to identify. 
Newborn hearing screening tests  
An  ideal screening test is that which would correctly differentiate 100% of the time 
between normal and hearing impaired persons(65).  
Screening or hearing test should therefore be objective, easy to administer, rapid and 
not time consuming, simple to use without complex cumbersome technological 
application, and economically suitable(66). Screening tests are useful for early diagnosis 
of hearing loss leading to early  effective treatment and decrease morbidity due to the 
disease (67) 
The true value of screening test is seen when it can identify mild to moderate hearing 
losses that can be treated which may progress to severe impairment if left 
undetected(65). 
Therefore identification of hearing loss through a `Newborn Hearing Screening 
Programme within the first month of life is important(66).  
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History of neonatal hearing screening 
The average age of picking up of congenital permanent hearing loss prior to the 
implementation of newborn hearing screening programmes, was around 2 years in 
North America, United Kingdom, and Europe, which caused  a further delay of fitting of 
the hearing aid by another 6 months(68) 
In 1970,  Professor David Kemp, was able to identify the tiny sounds that a healthy ear 
makes in response to sounds  called as the ‘otoacoustic emissions’ which could be 
analyzed in a  computerised screening system by the use of a microphone in few 
minutes.  Kemp then suggested that his discovery of the ‘otoacoustic emissions’ could 
be used as a screening hearing test. (68) In 1988 he, founded his own company in the US 
called “Otodynamics” where he developed the machine that could be used in newborn 
screening evaluations. (68) 
After Kemp’s discovery, Professor Adrian Davis and colleagues at the “Medical Research 
Company Institute of Hearing Research in Nottingham” began to work on otoacoustic 
idea, and proposed its capacity for highly sensitive screening programme. In 1988 
Professor Davis carried out multicentre trials in eight hospitals, for a total of 7,500 
babies who were at danger from hearing impairment. The conclusions were, that 
hearing impairment could be identified in approximately 80 % of babies screened out of 
the targeted neonatal hearing screening programmes (6) 
As a result in 1993, the US National Institutes of Health, held a consensus conference 
which recommended a national newborn hearing screening by using the otoacoustic 
test.(6)  
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In 2000, a pilot study of the otoacoustic test, screening of babies in intensive care was 
conducted and the Newborn hearing screening programme (NHS) was introduced in 
2002.  In March 2006 after evaluating the initial carrying out of the programme and  
after a long campaign from the National Deaf Children’s Society and the Royal National 
Institute for Deaf People, the universal test was initiated in England. (6)  Thus the 
Newborn Hearing Screening Programme had been instrumental in reducing the average 
age of detecting hearing loss from 20 months to three months(6) 
Universal neonatal screening 
In the US, prior to the implementation of the Universal neonatal hearing screening 
(UNHS) profoundly deaf children were identified at 2 years and children with mild to 
moderate hearing impairment were not identified until school going age.  With the 
introduction of UNHS programs, the early detection of hearing impairment in infants has 
changed considerably, (6) 
The first recommendation for the development of a nationwide "universally applied 
procedures for early identification and evaluation of hearing impairment" came in 1965, 
from the Babbidge Report of the Advisory Committee on Education of the Deaf.  
Before to the execution of universal newborn hearing screening, two important events 
took place which occurred in Rhode Island in 1989, Hawaii in 1990, and Colorado in 
1993. The first event was the development of objective non-invasive physiological tests 
for hearing loss that could be conducted by non-professional personnel. The second was 
the exhibition of the positive educational outcome of affected infants due to the early 
detection of hearing loss.  
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 In 1993, after meeting these prerequisites, the “National Institutes of Health Consensus 
Development Conference on Early Identification of Hearing Impairment in Infants and 
Children, recommended a ‘universal newborn screening programme (6).  
During the next 10 years, this initiative led to the gradual increase of programs across 
the nation (6). ‘Neonatal hearing screening’ later became incorporated as a universal 
screening programme. 
The Joint Committee on Infant Hearing (JCIH) issued a statement In 2000, 
recommending ‘universal screening’ for hearing impairment for all newborns before 
hospital discharge in addition to the guidelines outlined for hospital and state run 
programs.(64)  
 In 2010, after the approval by the Center for Disease Control and Prevention,  the 
programme was similarly recommended by the American Academy of Paediatrics (69).  
Hence the chosen option for public health care is Universal newborn hearing screening. 
A third of children with permanent hearing loss without this ‘early screening’ will be left 
unidentified for early rehabilitation. 
The Joint committee on infant hearing(JCIH)the position statement is 
The Joint committee on infant hearing (JCIH) recommendation is  he identification of 
children with hearing loss through the ‘universal hearing screening’  by the time children 
are discharged from hospital or within the first month of life. It was also recommended 
by the ‘Early detection and intervention of programmes’(EHDI)  for newborns with 
hearing loss. ‘EHDI aims at taking the advantage of the “linguistic competence and 
literacy development” for children who are deaf or hard of hearing.  
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These children will lag behind their hearing peers without this early detection and 
appropriate opportunities to learn language, in areas like cognition, communication, 
reading, and social-emotional development .(39) 
According to the Joint Committee of Infant Hearing (JCIH) recommendations, children 
should be referred to the appropriate medical expert and a speech therapist if the 
screening tests are positive. A ‘test battery’ is then undertaken to confirm the diagnosis 
of hearing loss which is made by the third month of life, and appropriate therapy 
initiated by the sixth month of life.(3)(70) 
Regular performance measurements of the children is recommended by the JCIH, along 
with regular monitoring of these measures for comparison and continuous quality 
improvement.(70) It also endorses the Screening of all infants before 1 month, and a 
comprehensive audiological evaluation not beyond  3 months, and appropriate 
intervention for those not passing the screening test not beyond  6 months of age.(39) 
It has been found that almost half of 95% of newborn infants that have been initially 
screened and referred in the United States, fail to come for the follow-up for either 
confirmation  of the hearing loss or early initiation of appropriate intervention 
services(40).  
Therefore a comprehensive approach for the assessment of infants is recommended  by 
the Paediatric Hearing Assessment Task Force called as the test Battery protocol’.(59) 
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The Test Battery Approach 
Here a variety of techniques in evaluating the hearing of the infants called as the ‘test 
battery approach’ is followed. It had been described in 1996 by Jerger and Hayes also 
called as ‘the cross check principle’. According to the current practice of paediatric 
audiology, a complete evaluation protocol:  behavioural, physiologic and, 
Electrophysiologic assessment, is followed.(59)  
The following is the paediatric audiologic assessment test battery for hearing loss:(59) 
 a) Behavioural observation  
 b) Visual Reinforcement Audiometry (VRA) 
 c)  Conditioned Play Audiometry (CPA) 
           - Frequency stimuli 
            - Speech Audiometry 
 d)  Physiologic Assessments, including 
            -  Acoustic Immittance, including tympanometry and acoustic reflex testing 
            -  Otoacoustic Emission (OAE) testing 
 e) Electrophysiologic Audiometry including  
            - Auditory Brainstem Response (ABR)  
           - Auditory Steady State Response (ASSR) audiometry (59). 
a) Behavioural observation  
This test is the “gold standard” of hearing evaluation. The behavioural testing aim is to 
identify hearing thresholds of the speech frequencies for each ear, and to asses’ speech 
awareness at a supra-threshold level, when possible, (59) 
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Behavioural Observation helps in the assessment of global auditory skill development. It 
is useful in newborns and infants below six-months of age and for those who are unable 
to participate in behavioural audiometry (59). The term ‘Behavioural Observation 
Audiometry’ or BOA is not appropriate, since this procedure does not determine hearing 
thresholds. In fact the preferred term is “Behavioural Observation”. The term 
“audiometry” should be set aside for tests of hearing ability. These observations are 
carried out in a quiet room after a brief examination of the child to rule out any 
congenital deformities. (59) 
Here the child is placed in quite state or light state of sleep, seated comfortably in car 
seat or on a resting pillow. If baby is placed in parent’s lap, parental masking should be 
considered. Parents are asked not to prompt their children when the stimulus is 
presented. Complex acoustic stimuli such as speech, speech shaped noise is presented 
between 60 and 90 dBHL, for a period of 3-4 seconds. To avoid misinterpretation of 
random child activity, ‘no sound’ or ‘catch trials’ are given.  Only about 2-3 stimulus are 
given prior to infant habituation(59) ‘Startle reflexes’ are looked for. 
 In this test, in response to auditory stimuli which is presented between 60 and 90 dB HL.  
The absence of a startle reflex should be analyzed with caution and in conjunction with 
other observations and test results, since the reflex can be present during hunger and 
fatigue. The results are recorded as “observational” and are not meant for any 
predictive auditory interpretation. For a final assessment of type and degree of hearing 
loss, the results from behavioural, physiologic and Electrophysiologic testing should be 
combined. (59) 
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b) Visual reinforcement Audiometry (VRA) 
The Visual reinforcement Audiometry (VRA) is done for Infants between 5 to 24 months 
of developmental age and is used to evaluate frequency-and ear-specific hearing 
sensitivity and hearing loss using a response that is conditioned. The test is performed in 
a Sound-treated booth after prior otoscopic examination and the establishing of hearing 
thresholds based on minimum response levels levels (MRL) are used. Parents are 
instructed not to prompt their children when a stimulus is given. A team testing 
approach is used when testing children who have developmental delays.   
Procedure: Earphones with ear tip or child’s personal ear mould or bone conduction 
vibrator or sound field speakers are used to deliver sound.  
Without any classical conditioning, when the presentation of the first stimulus is given, 
most of the children will show a definite spontaneous head turn within 2-3 seconds. 
Others may require certain classical conditioning, especially those with developmental 
delays. 
A 90 degree head turn is the response preferred for a VRA task rather than a 45 degree 
head turn which is less confusing for an audiologist to notice. In case a response to the 
auditory stimulus alone could not be elicited, the transducer is changed to bone vibrator 
to provide tactile stimulation at  a low frequency signal (e.g., 250 Hz) or speech is 
presented at a level that is known (e.g., 50 dB HL).(59) 
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c) Conditioned Play Audiometry  
This test helps to determine ‘ear-specific’ and ‘frequency-specific’ hearing sensitivity in 
children aged two to five years which is performed in a sound-treated room. It provides 
a quantitative analysis of the degree, type and configuration of hearing impairment.  
The child is put through a review of the play task motor response, after the otoscopic 
exam with adequate number of trials such that the child comprehends the instructions 
given. A brief initial training session, conditioning test is done to make sure that child 
understands the task.  
In response to an speech or frequency-specific auditory stimulus, appropriate play tasks 
like placing a peg in a pegboard, stacking blocks, tossing a block in a box, or other game-
type activities are given and analyzed.(59) 
 Speech Audiometry 
This test is done for children above approximately 6 months developmental age to 
determine ability of the child to perceive speech or speech like stimuli which includes 
speech discrimination, and speech recognition and speech awareness. Here a clinical 
test booth is not required and the test can be performed in a quite room. A threshold for 
speech is obtained prior to obtaining thresholds to frequency specific stimuli. 
Procedure: By using developmentally appropriate spondee words ‘Speech reception 
thresholds’ (SRT) are typically obtained. Response to the speech is made orally or by 
picture pointing with ‘closed set’ i.e. picture pointing tasks or ‘open set’ i.e. word or 
sentence repetition.  ‘Supra threshold speech perception’ testing is routinely conducted. 
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The examiner should modify the protocol, like pointing to various body parts if in case 
the child is unable to point to the pictures. If procedure is still unproductive, ‘speech 
awareness threshold’ (SAT) is obtained. (59) 
d) Physiologic Assessments:  
- Acoustic Immittance, including tympanometry and acoustic reflex testing 
- Otoacoustic Emission (OAE) testing 
Paediatric Immittance Testing 
1) Tympanometry 2) Acoustic Reflex Measures 
Paediatric Immittance Testing is done to asses for otitis media and other middle ear 
anomalies and to assess auditory pathway integrity and middle ear function. 
Routinely, Immittance assessment happen as a part of the hearing evaluation for Infants 
and young children who are at potential risk for middle ear diseases and those with 
known sensorineural hearing loss, or at risk for auditory neuropathy. 
Below 6 months of age, a higher probe tone frequency of 1000 Hz is used for neonates,   
The test is done  at low frequency probe tone of 226Hz, since it is more sensitive in the 
detection of middle ear disease than tympanometry and acoustic reflex done (JCIH, 
2007) (59) 
Tympanometry is normal, if a peak is observed at or near atmospheric pressure with 
admittance for the patient’s age.  
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It is considered abnormal if there is no identifiable pressure peak and “If the acoustic 
reflex threshold is > 95 dB HL for 500 and 4000 Hz; or > 100 dB HL for 1000 and 2000 Hz 
acoustic reflexes are abnormal. 
Acoustic reflexes help in identifying auditory neuropathy along with otoacoustic 
emission along with other clinical findings, since this reflex is always absent or increased 
in established cases of auditory neuropathy. The acoustic reflex alone may not be the 
best indicator of middle ear effusion but  a good indicator along with tympanometric 
gradient of less than 0.1 mmho, (B curve) and the absence of acoustic reflex for middle 
ear effusion  (59) 
Physiologic and Electrophysiologic tests 
Physiologic and Electrophysiologic tests are useful in assessing the auditory function as 
well as in the evaluation of auditory thresholds without needing behavioural response 
from the child. These tests are used as a part of Neonatal hearing screening to identify 
congenital hearing loss among infants. (59) 
Neonatal screening 
In the first month of life, detection of hearing loss  is done, through a Newborn Hearing 
Screening Programme(71).  Over all, the test is cost effective since the child would 
receive early intervention for hearing loss, and it saves on costly special education later 
on. Neonatal hearing screening later became incorporated as a universal screening 
programme.  
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Types of screening 
There are two primary types of hearing screening methods for newborns. 
1) “Otoacoustic Emission and 2) Auditory Brain Response Audiometry “(ABR) are the 
two auditory tests used in infant hearing screening programmes. For the identification of 
any degree of hearing loss, these electro-physiological methods are proficient, accurate 
and cost effective (66) 
The ultimate goal is to facilitate the child to develop cognitive abilities along with 
language and communication skills that match up to his chronological age (72). 
Behavioural observation audiometry can be used for screening, in the event the 
instruments for screening are not present. 
1) Otoacoustic Emissions Test 
Otoacoustic emission (OAE) is a valid method of testing cochlear function and is quick 
and cost effective 
It is useful for screening sensory loss in new-borns. (73) 
The advantages of Otoacoustic emission (OAE) are  
a) “It can be recorded in normal cochlea  
b) OAE can be recorded reliably from newborns.  
c) OAE can identify even mild hearing loss.  
d) A non-audiologic person can perform it.  
e) OAE recording requires relatively brief time.  
f) OAE provides frequency specific information”   
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OAE 
Evoked otoacoustic emissions(OAEs) are “acoustic signals produced from within the 
cochlea that travel in a reverse direction through the middle-ear space and tympanic 
membrane out to the ear canal” (59). These acoustic signals can be produced in 
response to an auditory stimulus like clicks or tone bursts.  
OAE helps to assess cochlear or outer hair cell function and can be done quickly at any 
age and on the child that is asleep or awake. A very sensitive microphone probe system 
picks up the signals of OAE which is kept in the external ear canal.  
To confirm type and degree of hearing loss, and or to detect the site of auditory 
disorder, OAE is used in screening neonates and children of all ages and can be utilized 
routinely as part of the paediatric assessment battery. Screening results can be 
influenced by the presence of middle-ear pathologies. Mild degrees of motion artefacts 
do not impede with the test.(59) 
For middle-ear anomalies and for moderate or more severe degrees of hearing loss, the 
OAE test is a good screening tool and can help in cross-check verification of behavioural 
testing when indicated. OAEs can also be utilized often to screen or monitor preneural 
auditory function because of the ease and speed of its administration.(59) 
A ‘failed’ OAE test shows that that the middle-ear condition is abnormal and the hearing 
loss is more than 30 to 40 dB.  The automated OAE screening machine provides a ‘pass-
fail’ report and therefore no special audiologist test interpretation is need. (59)  
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The disadvantage of OAE is that the reliability of the neural conduction of sound from 
the eighth nerve to the brainstem test cannot be assessed. Many will miss auditory 
neuropathy and other neuronal anomalies, as a result. Such children with auditory 
neuropathy will have normal OAE test results but abnormal auditory brainstem result 
(ABR).  
Two types of evoked OAEs are used for clinical assessment they are  a) ‘transient-evoked 
OAE’s (TEOAEs), which is produced using an acoustic click or other short transient sound, 
and b) distortion product OAEs (DPOAEs), can be obtained by giving two pure tones at 
the same time. 
Procedure: For the test, continuous surrounding noise in excess of approximately 50 to 
55 dB is avoided. The test is conducted in a quiet area where the ambient noise from 
outside sources is kept to a minimum. In the ear canal, the click stimuli are produced 
and the responses are evaluated by a probe assembly that is fitted to the ear disposable 
ear tips.  
For OAE recordings, stimuli used include transient clicks for (TEOAEs) and pure tones for 
(DPOAEs). Level of the stimulus for TEOAEs is around 80 dB peak, equivalents SPL +/-3 
dB as measured in the ear canal.  
In differentiating ears those with normal hearing from the ears in the 20 to 30 dB HL 
range with hearing loss, DPOAE uses pairs of pure tones i.e. lower and higher 
frequencies tones, where f1 = the lower primary frequency tone and f2 = the higher 
frequency primary tone. Currently, stimulus levels of L1=65 and L2=55 typically are used  
within a 10 to 15 dB difference between L1 and L2 (L1>L2).(59) 
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The newborns and neonates must be quite or resting, sitting quietly, after eating or 
around their naptime to record OAE. Otoscopy is done before the test to find the status 
of the external auditory canal and to determine the probe tip size to be used for testing.  
If a response is seen with signal-to-noise ratios (SNR) > 3 to 6 dB in the majority of 
frequency bands analysed, TEOAEs are considered to be present and normal. If a 
response is not seen with a SNR of ≥3 to 6 dB in more than one frequency band TEOAEs 
are considered to be ‘absent’  
If the distortion products are observed at a signal-to-noise ratios (SNR) > 3 to 6 dB at the 
majority of frequency bands, DPOAEs are considered to be present and normal   
DPOAEs are considered absent if a response is not noticed with a ≥3 to 6 dB SNR for 
more than one f2 frequency; the results are analyzed within the context of a test battery 
for diagnostic purposes. When OAEs are present at normal amplitudes throughout most  
of frequency bands evaluated results are reported as reliable with the functional 
integrity of the outer hair cell system (59) 
Auditory Brainstem Response Test 
History of ABR 
In 1967, the first to publish Auditory Brainstem Response (ABRs) recorded with surface 
electrodes in humans beings were Sohmer and Feinmesser    
They demonstrated that cochlear potentials could be elicited with a non-invasive 
method. In 1971, Jewett and Williston described the human ABR waves and as arriving 
from the brainstem.  
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Later In 1974, Hecox and Galambos described in adults and infants that the ABR was 
suitable for threshold assessment. Starr and Achor in 1975 were the first to report the 
effects on the ABR of CNS pathology in the brainstem.(67) 
The Auditory Brainstem Response Test (ABR) is an effective and non invasive 
electrophysiological measurement for assessing the brain stem auditory sensory 
pathway and the functional status of the auditory nerve. The condition of the inner ear 
and or auditory nerve can be obtain through ABR and is an objective way of recording 
brain stem potentials in response to click stimuli.(67) By electrodes placed over the 
scalp of the person, these waves are picked up. This test gives information on the 
degree, the type, and composition of a hearing loss. Because it is fairly an accurate and 
reliable indicator of hearing loss, it is considered as an important procedure in the initial 
test battery, in infants who are very young to respond to behavioural testing.(67)  
The ABR is used for various assessments like the newborn hearing screening, auditory 
threshold evaluation, auditory nerve brainstem lesion detection, determining hearing 
loss type and degree, and  intra-operative monitoring. The ABR test is done, after the 
otoscopic exam, in a sound treated booth or a quiet room. The standard electrode is a 
‘non inverting’ electrode which is placed on the vertex, and another ‘inverting electrode’ 
is fixed over the ear lobe or mastoid prominence. (Fig 7 b-c)  
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Fig 7a Vertex Electrode for ABR   Fig 7b: Mastoid electrode for ABR   Fig 7c: electrodes 
+Transducer fixed 
One more ‘earthing electrode’ is fixed over the forehead of the infant (Fig 7a). For 
proper functioning of the preamplifier this earthing electrode is important(67) 
 
                                              Fig 8   Placement of Electrodes for ABR(67) 
The stimulus in the form of ‘click’ or ‘tone pip’ is sent to the ear via a transducer placed 
in the head phone or insert ear phone (fig 9). The impulses from the brain stem in the 
wave forms are picked up by electrodes placed over the scalp.                            
                                               
                                               Fig 9: Transducer placed in the ear 
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Signal to noise ratio (Sound signal given to the ear against the background noise) in ABR 
is improved by filtering, repeated stimulation and by polarity alteration. 
 In auditory brain stem evoked response audiometry, the areas of the response that are 
neural and those that are cochlear such as the cochlear microphonics, are differentiated 
by alternating the polarity of the tone bursts. (75) 
6 ms or less tones or tone bursts or pips which consists of at least 3 cycles of the 
specified frequencies which are of short duration are used along with stimuli of nominal 
octave frequencies from 250 or 500 to 4000 Hz(59). The amplitude in micro voltage of 
the signal is averaged and recorded against the time in milliseconds.  
The waves in the form of positive peaks and negative troughs by the impulses generated 
by the brain stem are recorded. After a click stimulus is given, these waveforms are seen 
usually within a 10-millisecond time period, at high intensities of 70-90 dB normal 
hearing level. The positive peaks (vortex positive) are indicated by the Roman numerals I 
– VII (Fig 8, 10).(75) 
These peaks are considered to originate from the following anatomical sites: 
Cochlear nerves - waves I and II 
Cochlear nucleus - wave III 
Superior olivary complex - wave IV 
Nuclei of lateral lemniscus - wave V 
Inferior colliculus - waves VI and VII” 
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These peaks occur over a period of 1 - 10 milliseconds, in response to a click stimuli after 
the stimulus is given in normal hearing. Its threshold as elicited by conventional 
audiometry has been found to be within 10dB. (67) 
 
                          Fig 10- Normal adult brainstem response (ABR)(75)  
Interpretation of results 
The results of ABR can be interpreted by looking at the a) amplitude (the number of 
neurons firing), b) latency (the speed of transmission), c) interpeak latency (the time 
between peaks), and d) interaural latency (the difference in wave V latency between 
ears)  
The activity of the neuron that begins at the base of the cochlea and moves toward the 
apex over a 4ms period of time is sown by ABR. Beginning from the most basal regions 
on the cochlea the peaks usually show activity. Initially, any disturbance affects the basal 
end and a significant amount of phase cancellation occurs by the time it gets to the 
apex,.(75) 
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Auditory Brainstem Response Test (ABR) can be done without sedation and does not 
require the child’s participation in infants less than 5 months of age. It is considered the 
method of choice for hearing screening. The specificity and sensitivity rate reported by 
Hall et al have been more than 96% for ABR screening in the new-borns(75) 
The advantages of ABR are(67) 
1. It is objective measurement of auditory system. 
2. It provides ear specific information. 
3. It is independent of subject’s state (sleeping, awake). 
4. It does not require sound booth for evaluation. 
5. ABR is independent of cerebral status. 
6. Helps in detecting auditory neuropathy(67) 
Auditory Steady State Responses (ASSR) 
ASSR, is another electrophysiologic measurement of infant’s hearing. It provides more 
“frequency-specific threshold information” regarding the neonates who have severe to 
profound hearing losses. To have more accurate information to go ahead with hearing 
aid fittings or to determine the cochlear implant for the candidate this test is useful. 
Sedation may be needed for infants over 6 months of age for ASSR testing.  
At the present time, the recommendation of this procedure as the only measure of 
auditory status in newborn and neonatal populations has not been given by the Joint 
Committee on Infant Hearing (JCIH) 2007 Position Statement.(70)  
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ASSR vs ABR (78) 
Similarities: 
a) “Both record bioelectric activity from electrodes arranged in similar recording arrays. 
b) Both are auditory evoked potentials. 
c) Both use acoustic stimuli delivered through inserts (preferably). 
d) Both can be used to estimate threshold for patients who cannot or will not 
participate in traditional behavioral measures”. (76) 
Differences:   
a. “ASSR can be used binaurally while evaluating broad bands or four frequencies (500, 1k, 
2k, & 4k) simultaneously, but ABR typically uses click or tone-burst stimuli in one ear at a 
time. 
b. The ABR estimates thresholds from 1-4k in typical mild to moderately-severe hearing 
losses where as ASSR can also estimate thresholds in the same range, but offers more 
frequency specific information more quickly and also can estimate hearing in the severe-
to-profound hearing loss ranges. 
c. ABR depends highly upon a subjective analysis of the amplitude/latency function. A 
statistical analysis of the probability of a response (usually at a 95% confidence interval) 
is used by ASSR. 
d. ABR is measured in micro volts (millionths of a volt) and the ASSR is evaluated in 
nanovolts (billionths of a volt). 
e. The ASSR is an evoked response which uses sound which is given at a high repetition 
rate rather than a onetime sudden sound at a low repetition rate”. (76) 
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Automated Auditory Brainstem Response (aABR) test 
The ABR is one physiologic objective method of hearing screening. Information about 
the outer ear, middle ear and cochlea is provided by the automated auditory brainstem 
response (aABR) screener and also gives information regarding the auditory pathway up 
to the brainstem. The brain activity in response to sounds is recorded by the aABR 
screening test. The sound waves travel through the outer ear as vibrations where it is 
changed into an electrical signal when it reaches the cochlea. To reach the brain, these 
electrical signals now travel along the eighth nerve where it is processed into 
recognizable sounds. The instrument measures the cochlear response to the broadband 
click stimulus in the 1- to 4-kHz range in each ear. 
The aABR test uses a series of clicking sounds at 35 dB near hearing level, which are 
played through the headphones that are placed over the baby’s ears. Three small 
sensors are kept on the baby’s head which are attached to the computer equipment. 
The computer will report strong responses as ‘pass’ if the hearing system normal. The 
computer will report a ‘referral’ when there is no strong response to the stimulus. (57). 
Usually 3 out of 100 babies will be referred for a full diagnostic assessment of hearing. 
Advantages 
a) Automated ABR screener (aABR) is time and cost effective which has a ‘high sensitivity 
and a ‘low failure rate(67) 
b) It can be used on the ward where no operator assessment is needed. It can also be used 
without interference from ambient noise during oxygen therapy. 
c) The time needed for screening is from 4 to 15 min(66). With the same results, aABR can 
be used in a home setting, 
60 
 
d) Further test interpretation by an audiologist is not needed, since the automated 
screener gives a ‘pass-fail’ report. A ‘fail’ report given by an aABR show that the hearing 
level is worse than 40 dB. 
e) Can test each ear individually .The aABR can be performed on children of any age 
f) The test can be repeated when motion artefacts interfere with test results (7) 
g) For universal hearing screening, the AABR has acceptably low ‘refer’ rate. 
h) Can be used after birth within the first 24 hours in the nursery, by various personnel. 
i) The low rate of screening failures decreases any potential of false-positives during 
screening, minimizing the costs associated  with later follow-up  assessments.(75) 
j) Even in the nursery, It can identify mild, moderate, and severe bilateral, persistent 
hearing loss which helps to provide amplification before 6 months of age and thus 
facilitates speech and language development.(75) 
Several ABR screening instruments incorporate built-in artefact rejection for myogenic, 
electrical, and environmental noise interference, which ensures that data collection is 
halted if testing conditions are unfavourable. 
Neonatal hearing screening programs have been initiated in many countries across the 
world. In India the universal hearing screening had been initiated in few areas like cochin 
since January 2003.(77). 
aABR Versus OAE screening 
For hearing screening, two methods are used. One is dependent on the measurement of 
otoacoustic emissions (OAE) and the other is dependent on the Auditory Brainstem 
Response (ABR).  
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The sensitivity of ABR is superior to that of OAE, among the screening tests, because, the 
OAE is not able to distinguish retrocochlear hearing impairments, such as ‘auditory 
neuropathy’ which has a prevalence of 5–10% among the newborns.  
The MB11 BERAphone gives an automatic ABR at the speed and cost of OAE 
measurement along with very high sensitivity and specificity. (75) 
Several machines are available in the market for neonatal screening that provide aABR 
and OAE screening. (76) 
 
Table 5. Machines available in the market for Neonatal screening.(78) 
Since the aim of neonatal hearing screening program is to detect all types of permanent 
hearing loss along with those that are due to dys-synchrony and auditory neuropathy, an 
ABR-based method is chosen. 
 ABR screening by MB11 BERAphone, can be performed without the use of disposable 
and adhesive electrodes, and the additional operational costs associated with traditional 
ABR screening devices is also low.(75) 
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MB11 BERAphone® screening device 
Traditional click stimulus’ or ‘time step stimulus’ was used in the first type of the 
BERAphone® machine to obtain the ABR.  
A series of six successive clicks in diminishing intensities of 10 dB steps are given at 
intensities ranging from 60 to 10 dB HL. ABR thresholds analysis of the screened 
newborns was done visually and interpreted by an experienced clinician.  
In 2002,a new algorithm based on statistical analysis for ABR data was introduced, to 
replace the visual analysis time step ABR, making the screening fully automatic.(75) 
For evoking higher ABR amplitudes, a new, device with optimized ‘chirp stimulus’ was 
incorporated in the screening machine in 2006. Due to this, vast improvement was seen 
in the screening quality and detection rate. Regularly, since then the MB11 BERAphone® 
has been used for neonatal hearing screening with the optimized chirp stimulus.  
For newborn hearing screening, White et al had done another comparative study with 
MB11 BERAphone® using a chirp stimulus and the ABaer -aABR.  MB11 showed a 
considerable advantage for the testing time of 2.3 min compared to the ABaer which 
had taken longer time of 6.9 min. (75) 
Melagrana et al also in their study concluded that screening of  babies in an intensive 
care environment with MB11 screening test was appropriate.(75) 
The MB11 BERAphone® device (7) 
The Maico MB11 BERAphone® is a dependable machine for auditory brainstem response 
newborn hearing screening; in addition it gives results quickly.  
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Owing to the automatic detection of ABR, the instrument does not need the assistance 
of an experienced examiner, therefore can be used by any trained technicians (75) 
An earlier study done at CMC found BERAphone to be a very suitable tool for neonatal 
screening in the ward by the bedside.  
The device, MB11 BERAphone® is fitted with a handheld ‘headphone unit’ that has all 
the ingredients needed for ABR recording such as the loudspeaker, a preamplifier and a 
set of three integrated, reusable electrodes.  
Test preparation time for an ABR screening is short, since additional materials like 
disposable electrodes or ear couplers need not be attached to the skin for the screening.   
Features: 
- Fast and automatic ABR-screening, reliable results within seconds 
- Unique BERAphone® with integrated electrodes saves costs for disposables 
- CE-Chirp-Stimulus ensures fast results 
- Automatic Impedance Check indicates impedance conditions 
- Export function of test data for quality ensuring tracking 
- Stimulation level at 35 dBHL 
- USB connection for power supply and data transfer” 
Sensitivity >99.9% 
Specificity > 96.7% 
64 
 
Beraphone Screening tests the entire auditory pathway up to the brainstem with 
auditory brainstem response. In addition, it also detects conditions like the auditory 
neuropathy and other neural defects which cannot be made with OAE testing.(79) 
The hand held unit has of two electrodes that can be used to trace the ABR recordings 
from the vertex and from the mastoid, and a third electrode functions as the ground 
reference. An adjustable ‘vertex electrode’ is present for its proper placement on 
different sizes of heads. (75) 
  
Fig 11:. MB11 BERAphone® device with the three electrodes  
Since 2006, MB11 BERAphone® CE-Chirp™,  had incorporated an optimized ‘chirp 
stimulus’ for the  
hearing screening. The waveform of the chirp stimulus is seen in Fig 12.  
 
Fig 12: The ‘temporal waveform’ of chirp stimulus used in the MB11 BERAphone®. 
65 
 
In comparison to typical ‘click stimuli’, the MB11 generates high chirp stimulation at the 
rate of 92 stimuli per second which is designed to decrease the delay in time for the 
production of a threshold response. In contrast the MB11 click stimuli, attempts to 
enhance the temporal synchrony among the neural responses from various regions on 
the basilar membrane. (75) 
To identify the presence of an ABR response automatically, the device takes a maximum 
test time of 180 seconds and which is based on an implemented statistical test algorithm 
(modified q-sample uniform scores test) as given by Cebulla et al. This implemented test 
algorithm attempts to detect a response from the auditory system. The screening test 
generates a “PASS” result when a response is detected. The screening test generates a 
‘REFER’ result if there is no response within 180 s (75). 
The device is set to the screening stimulus level of 35 dB HL for a “Pass. This acoustic 
calibration is made by the manufacturer and yearly recalibration of the machine is done 
by the medical service team of the manufacturer.  
Two stage protocol 
The screening protocol included two stages. The first stage includes an initial screenings 
by Beraphone which is recorded at the bed side of the nursery within 48 h of delivery. 
Both ears of the infant are tested. The result shows ‘PASS’ when the response to the 
stimulus is below 35 dB HL and “Refer” when either of the ears shows no response to all 
the frequencies presented.  
The second stage screening is done in the Department of Audiology where the 
audiological diagnostic tests are done in an acoustically shielded room.  
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The newborns that generated a ‘Refer’ were re-tested after a week, as per the second 
stage of the hearing screening protocol, in the department of audiology.  
Two step screening protocol is followed because screening immediately after birth often 
results in high false positives due to vernix plugs in the baby’s ear canals therefore a 
more effective way of minimizing over-referral due to false positives is to implement a 
two-stage screening protocol with aABR first, followed by a diagnostic test such as ABR. 
(66)(75) 
This protocol also improves the specificity where it is able to correctly identify those 
who do not have the disease. Also the two step screening is a standard practice in 
western countries for the universal screening programme (75) 
The manufacturer reports that the ‘BERAphone’ has a sensitivity more than 0.99 and 
test specificity of 0.87 for a one time test and  as a two-stage test, the specificity is 
greater than 0.96.(7) 
Van Straaten et al, in his study of using automated ABR, reported a 92% ‘pass’ in the first 
screening and 98% ‘pass’ after the second screening (66) 
Such high values of sensitivity and specificity are only possible when testing is done 
under ideal conditions. Where as in a tertiary care centres like CMCH where the annual 
delivery rate is more than 13,000 the above mentioned testing in ‘ideal’ conditions is not 
possible to get a universal neonatal screening. This has made it necessary to test babies 
at the bedside to accomplish such high coverage.  
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                                             Fig 13 Bed side neonatal screening 
 
This study is therefore intended to calculate the sensitivity and specificity of this 
neonatal hearing screening tool ‘MB11 BERAphone® when used at the bedside of an 
infant in a ward setting in less than ideal conditions against the gold standard diagnostic 
test ABR done in ideal conditions. The ideal conditions include an air conditioned sound 
proof room where the sound levels are less than 35dB. 
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MATERIALS AND METHODS 
The main objective of this study was to determine the sensitivity and specificity of MB11 
BERAphone® as a screening tool in identifying neonates with congenital hearing loss in 
comparison against the gold standard, ‘Auditory Brain Stem response Audiometry’(ABR) 
when performed at the bedside of the new born at the postnatal ward setting where the 
sound levels are over 35dB. 
This is an observational study performed between October 2012 to October 2013 at the 
Christian Medical College, Vellore (CMCH), after institutional review board and ethical 
committee clearance. Neonates  born in CMCH that have been referred once on 
sequential screening with MB11 BERAphone® were recruited after obtaining informed 
consent from the parents.  
The sample size for the study was obtained as follows:                                                
No of ears                                                
 
 
 
 N = Total sample size, Z = Constant – (1.96), P = Expected Sensitivity – 0.95 
(   )  
(    )               
(    ) 
   
           
      
       
                                                                          
n = (a+c) 
N= (a+c) / prevalence 
 Δ   = precision 
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For an expected sensitivity and specificity of 95% each and prevalence (in the second 
screen positives) of 0.5 and a precision of ± 0.07 %, a sample size of 74 will be required 
for the estimation of both sensitivity and specificity of the screening tool MB11 
BERAphone®. 
37 consecutive healthy neonates (which would make up to 74 ears) born in CMCH during 
the study period of one year, and who have been ‘REFERRED’ once on sequential first 
screening with MB11 BERAphone® fulfilling inclusion and exclusion criteria were 
recruited for the study which was performed in the postnatal ward setting, and in the 
Audio vestibular unit after obtaining  informed consent from the parents. 
Inclusion criteria:     
a. Infants born in CMCH. 
b. 37 Neonates who were ‘REFERRED’ after the First MB11 BERAphone® test.  
Exclusion criteria:  
a. Upper respiratory tract infection 
b. Discharging ears 
c. Very sick new born. 
d. New born with obvious anomalies. 
e. Parental refusals. 
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The screening protocol included two stages ( two step protocol) (Fig14). 
                
                                                                                                                          Discharged      
 
 
 
 
                       Fig 14: Two stage protocol for Neonatal screening 
In the first stage, the initial screening was done in the postnatal ward prior to hospital 
discharge within 48 hours of delivery at normal ambient sound levels which were above 
35dB. 
 The neonatal screenings both the first and second were done by MAICO MB11 
BERAphone® (MAICO Diagnostic GmbH, Berlin / Germany). The MB11 BERAphone® is a 
screening device that is fitted with a handheld ‘headphone unit’ that incorporates all the 
ingredients required for ABR recording like the loudspeaker, a preamplifier and a set of 
three integrated reusable electrodes. The time required to prepare for an ABR screening 
test using this equipment is brief because it is not necessary to adhere disposable 
electrodes or ear couplers to the skin.  
First screening MB11 BERAphone® in postnatal ward 
in ambient noise setting 
                                                                          
                                                         
                              Refer                            Pass   
 
                                                                            
 
 
                                                                             
 
     Tests performed in sound treated rooms 
 
 
         ‘Referred’               ‘Pass’  
 
 
37 Newborns with 
unilateral/Bilateral ‘Referral’ 
Second screening MB11 BERAphone® 
 
Confirmation with ‘Gold Standard’ 
ABR  
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Two electrodes are used to record the ABR from the vertex and mastoid, while a third 
electrode is used as a ground reference. The position of the vertex electrode is 
adjustable to enable its optimal placement on different head sizes. 
    
  Fig 15a: BERAphone unit                            Fig 15b: BERAphone headphone unit 
From start of the study for a period of one year the mothers or carers were counselled 
about the test (Appendix item no - 1) and consent taken (Consent form Appendix item 
no-2)  
A complete case history with important developmental and medical history that includes 
prenatal and perinatal history was obtained from parent or primary care taker of the 
infant (Appendix (Performa) item no-3).  
History pertaining to various risk factors for hearing loss (TORCH infections, diabetes, 
hypothyroidism, ototoxic drug intake and other illnesses) was recorded. Family history 
with regard to deafness, blindness and other systemic diseases were noted. Complete 
physical and ENT exam was done. The external ear was examined for any malformations 
in and around the pinna, position of the pinna and any lesions or cysts on the pinna. 
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Detailed otoscopic exam was done to determine the size and direction of the ear canal 
for the placement of probes or inserts used during testing.   
The screening process was organized and supervised by the Audio vestibular unit of the 
department of ENT. The measurement with the MB11 BERAphone® was performed by 
support staff recruited from the department of audiology. The screeners had received 
prior training on the use of the device. 
The mother was asked to feed the child and when asleep or quiet, the special hand-held 
headphone unit of MB11 BERAphone® which emits a series of soft clicks was positioned 
over the newborn's ears after application of electrode gel.  The electrodes which are 
present within the unit were positioned on the infant's forehead and neck. Two 
electrodes record the ABR from the vertex and mastoid, while a third electrode is a 
ground reference.  
  
Fig 16: MB11 BERAphone® hand held device with three integrated electrodes and 
transducer 
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The vertex electrode is adjustable to ensure its proper placement on various head sizes. 
These electrodes measure the brain wave activity in response to the clicks or chirp 
stimulus. The tests are non-invasive, painless and quick.  
The test takes 1.5 minutes per ear when the response is good, and about 4.5 minutes 
per ear when there is no clear response from the ear. 
Comparison of the brain wave activity with normal response templates is done by the 
software in the laptop which is connected to the MB11 BERAphone® and provides a 
‘PASS’ or ‘REFER’ result. If a response is detected and verified at 35 dBHL, the test result 
is ‘PASS’. The machine indicates a ‘REFER ‘when there is no response at 35 dBHL at all 
frequencies.  
      
Fig 17: BERAphone screening test results ‘PASS’ and ‘REFER’ 
The second stage screening along with all audiological diagnostic tests were performed 
in an electrically and acoustically shielded room in the department of audiology where 
the noise is relatively low.  The mothers/carers, after counselling were asked to report to 
the department of Audiology in the out-patient department after a period of one week 
for the second screening and for the confirmatory test.   
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This was done to overcome the possibility of vernix in the ear of the neonate interfering 
in the first screening soon after birth. Similar to the first screening the mother was asked 
to feed the child and when asleep or quiet the second screening was done with MB11 
BERAphone® in a sound treated audiology room. 
All the 37 infants who had been ‘REFERRED’  or ‘PASSED’ in the second screening with 
‘MB11 BERAphone® were subjected to a confirmatory diagnostic testing with ABR 
(Auditory Brainstem response) which was used as the Gold standard for confirming the 
hearing loss in neonates recruited for the study.  
The second screening with the MB11 BERAphone® was done at the same sitting prior to 
the ABR test. 
The subset of children who were ‘Referred’ in the first screening and have ‘Passed’ in 
the second screening (where the tool says no hearing loss) were also subject to the 
confirmatory ABR testing to provide the second arm of the 2x2 table for calculation of 
sensitivity and specificity.  
 
Fig 18: ABR Testing 
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Following the second screening, the neonates underwent the confirmatory test Auditory 
Brain stem Response audiogram (ABR) using Intelligent Hearing Systems ABR Machine 
ISO 13485, Miami, Florida.  
The ABR test was done in a sound proof room by an experienced audiologist who was 
blinded to the results of the first and second screening by MB11 BERAphone® under 
standard conditions.  
The procedure of the test was explained to the mothers/carers and once the neonate 
was comfortable, dry, breast fed and naturally sleeping the infant was placed in a secure 
area for testing. The skin for electrode application was prepared by carefully cleaning 
and mildly abrading the skin. The positive ‘non-inverting’ electrode was placed on the 
vertex at the midline and the negative ‘inverting’ electrode was placed on the mastoid. 
The ground electrode was placed on the opposite ear. It was ensured that the electrode 
impedance was kept to a minimum (< 5 kOhms).  
   
Fig 19: Confirmatory testing by ABR 
The signal was delivered through insert earphones. The stimulus used was a click signal 
which was presented at various intensities to obtain the air conduction threshold of the 
ear. The threshold of hearing is taken as the lowest intensity at which repeatable wave V 
becomes visible on ABR tracing.   
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The ambient sound level was tested in the ward the Audiology room and the ABR room 
with sound level meter CENTER 322 - Sound Level Meter (Data logger) Center 
Technology Corp, Victoria, Australia..  
 
Fig 20 Sound Level Meter (Data logger) 
The data presented in the first screening was collected in the prenatal ward as part of 
the newborn hearing screening program. This protocol till now is the normal standard of 
practice offered to the patients.The results of the history and examination were 
recorded and evaluated at the end of the study. The analysis of the second screening 
was maintained separately in the department of audiology and a separate register 
maintained for the ABR confirmatory tests.  At the end of the study period, the results 
were finally compared and the analysis was done by the study physician.  
Statistical analysis: 
The data of all the patients was collected systematically using the software EPIDATA 
version 3.1. All statistical analysis was performed using statistical software STATA 
(version 10.0), STATA corporation, Texas, USA. The sensitivity, specificity, positive and 
negative predictive values were calculated using this software. 
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RESULTS 
Of the 37 newborns screened during the 13 month period  23(62.2%) were males and 
14(37.8%)were  
females 
.  
Fig 21: Male and female ratio of the study population 
Prenatal variables 
a) Consanguinity 
Among the total of 37 neonates (100%), 8 neonates (21.6%) were born of 
consanguineous marriage and 29(78.3%) of non-consanguineous marriage. Among the 8 
neonates of consanguineous marriage, 5 (23.3%) neonates were bilaterally referred, and 
3(19.4%) showed bilateral pass in the second BERAphone screening. Among them only 
one neonate was a confirmed case of bilateral hearing loss. There was no difference in 
the proportion of ‘PASS’ and ‘REFER’ among the consanguineous group of neonates.  
62% 
37.80% 
M:F Ratio  
Males- 23
Females- 14
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From the 29 neonates born out of non consanguineous marriage, 23 (79.3%) were 
‘Referred’ and 7(24.1%) from them showed confirmed hearing loss.  
b) Parity 
Out of the 37(100%) neonates in the study, 17 mothers were primigravida and 20 were 
multigravida. 8 neonates of primigravida mothers showed ‘REFERRAL’ and 3 of them 
were confirmed to have hearing loss. Among the neonates of multiparous mothers 19 
were “REFERRED’, 3 of them were confirmed to have hearing loss. 
c) Gestational age 
Gestational ages at birth of all the newborns recruited in this study were above 36 
weeks of gestation and hence all the study newborns were within the accepted normal 
gestational period and were not born preterm. 
  Prenatal Risk factors 
Two mothers had associated maternal risk factors.(Table 6 ) 
Risk factors Present % Absen
t 
% Total 
Maternal Diabetes 2 5.4% 35 94.6% 37 
Hypothyroidism 1 2.7% 36 97.3% 37 
TORCH 0 0 37 100% 37 
Ototoxic drugs 0 0 37 100% 37 
Others 0 0 37 100% 37 
Total ears     74 ears 
Table 6: Prenatal risk factors and the screening outcome. 
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One mother had maternal diabetes and hypothyroidism and underwent delivery by 
Caesarean section. The neonate of this mother showed bilateral ‘referral’ in the second 
screening and hearing loss was confirmed in the left ear by ABR. Another mother had 
maternal diabetes. The second screening for this neonate showed bilateral ‘referral’ and 
bilateral hearing loss was confirmed by ABR. 
Perinatal variables 
Table 7 shows the list of various perinatal risk factors. Of the 37 neonates in the study 3 
neonates had birth weight <2.5kg, all 3 showed confirmed hearing loss. There were12 
neonates born by LSCS of these 9 neonates were ‘referred’ of these 4 neonates had 
confirmed hearing loss and rest of the 8 showed normal hearing. Among the other risk 
factors two had neonatal jaundice, one had seizure and one infant had bacterial 
infection. From these, 3 were ‘REFERRED’, but only one had confirmed hearing loss.  
  Frequency 
no 
Ref % Second Screening 
‘Refer  
ABR 
HL 
Apgar <7 0 0   
BT Wt- <2.5kg 
 
3 7 % 3 3 
Instrumental delivery  12 32.4% 9 4 
Bacterial Infection 1 2.7% 0 0 
Jaundice 2 5.4% 2 1 
Seizures 1 2.7% 1 0 
Aspiration 0 0 0 0 
Meconium  aspiration 0 0 0 0 
Meningitis 0 0 0 0 
Ototoxic drugs 0 0 0 0 
NICU 0 0 0 0 
Total 19  16 8 
Table 7: Perinatal risk factors and confirmed hearing loss 
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Among the total of 19 neonates with perinatal risk factors, eight of them had hearing 
loss. 
First and second screening results 
The first screening consisted of all 37 neonates that were ‘Referred’ and recruited in the 
study which make up a total of 74 ears. Of these 13 (35.10%) infants had bilateral 
‘REFERAL’ and 24(64.80%) neonates had unilateral ‘referral’. All of them were subjected 
to the second BERAphone screening. 
 
Fig: 22. Results of ears tested in first screening 
The 37 newborns who participated in the second stage of the screening process 
provided 74 ears for comparative testing against the ABR.  Of the 74 ears of newborns 
referred for the second stage screening, 31(41.9%) ears passed and 43 (58.1%) ears 
were referred again. Therefore the pass rate for the second screening was 41.9 % and 
the referral rate was 58.1 % (Fig 24). 
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Fig 23: Second BERAphone screening results 
 
Figure 24: Number and percentage of ears that were bilaterally and unilaterally referred 
at second referral.  
At the second screening 15 infants showed bilateral ‘REFER’, 13 infants showed 
unilateral ‘REFER’ and 9 infants have shown bilateral ‘PASS’ 
58.10% 
41.90% 
Second BERA results 
Total Ref-43
Total Pass-31
24.30% 
40.50% 
17.60% 
0.00% 10.00% 20.00% 30.00% 40.00% 50.00%
2nd Bera
U/L ref ears-13
B/L ref ears-15
B/l pass ears-9
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ABR Confirmation of hearing loss 
On confirmatory testing by ABR, of the 74 ears tested, 14 ears (18.9%) had confirmed 
hearing loss and 60 ears (81.1%) were normal which represents a percentage of 
confirmed hearing loss of 18.9% and a pass level of 81.1%. (Fig 24) 
 
Fig 25:ABR confirmation of total Hearing loss 
 
Fig 26: ABR confirmation of unilateral and bilateral hearing loss 
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ABR confirmation showed that of the 9 neonates with hearing loss, 5 neonates had 
bilateral impairment and 4 neonates had a unilateral impairment. 
Sensitivity, Specificity, PPV NPV for BERA2 with ABR 
 ABR Hearing loss ABR Pass Total 
BERAphone 
‘Refer’ 
13 
92.9% 
30 
50.0% 
43 
58.1% 
BERAphone 
‘Pass’ 
1 
7.1% 
30 
50.0% 
31 
41.9% 
 14 60 74 
100% 
Table 8: BERAphone second screening with ABR confirmation 
The purpose of the study was to calculate the specificity and sensitivity of the neonatal 
screening tool MB11 BERAphone® (Maico diagnostic, Germany) when used in the ward 
setting.   The table 8 shows the results of second BERAphone when confirmed with ABR. 
  
Fig 27: Showing true and false positive and negative test results 
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The test results show 93% were true positives and 50% were true negatives. 50% 
showed false positive results with the second screening and 7% showed false negative 
result. 
 ABR 
Referred 
ABR 
Pass 
Total 
BERA Referred 13 (a) 30 (b) 43 
BERA Pass 1 (c) 30 (d) 31 
Total 14 60 74 
 
Sensitivity 93% 
Specificity 50% 
Positive predictive value 30% 
Negative predictive 
value 
97% 
Prevalence  18% 
Table 9: Sensitivity, Specificity, Positive and n-Negative predictive values. 
Sensitivity means “the ability of the test to identify correctly those who have the 
disease” and specificity indicates “the ability of the test to identify correctly those who 
do not have the disease” 
The sensitivity and specificity were calculated by using the formulae 
sensitivity=a/a+c(true positives/disease) and   specificity=d/b+d(true negatives).  
 
1. Sensitivity of BERAphone in detecting congenital hearing loss in infants in the ward 
setting  
Sensitivity = 
  
  
              
Sensitivity of BERAphone 93% (95% CI: 66.06 % to 98.81 %) 
2. Specificity of BERAphone in the infants in the ward setting 
Specificity = 
  
  
            
Specificity of BERA 50 %( 95% CI: 36.81 % to 63.19 %) 
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The sensitivity of a 2 stage screening with BERAphone was 93% while its specificity was 
50%.  
3. Positive predictive value of BERAphone (PPV)  
PPV = 
  
  
            
PPV = 30.23% (95% CI: 17.20 % to 46.13 %) 
The positive predictive value of the 2 stage BERAphone screening was 30%  
4. Negative predictive value of BERAphone (NPV)  
NPV = 
  
  
            
NPV = 96.77% (95% CI: 83.24 % to 99.46 %) 
Negative predictive value was 97%, compared to the ABR (Table 9).  
The prevalence of hearing loss in this study group was 14/74, = 18.9%.(19%) 
The diagnostic results in Table 9 shows that of the 28 neonates (43 ears) who failed the 
2nd stage screening, 9 neonates were confirmed with ABR as having a hearing 
impairment which required intervention. Of these 5 neonates had a bilateral impairment 
and 4 neonates had a unilateral impairment.  
The remaining 28 neonates were found to have bilaterally normal hearing after 
confirmation.  
The MB11 BERAphone screening yielded 1 false negative (7.1%) and 30 false positives 
(50%). Efficacy of MB11 showed a sensitivity of 92.9% and a specificity of 50%. The 
positive predictive value (PPV) was 30.23% (95% CI: 17.20 % to 46.13 %) and negative 
predictive value (NPV) was 96.77% (95% CI: 83.24 % to 99.46 %) for the diagnosis of 
hearing loss. 
Hearing loss 
The observed prevalence of confirmed hearing impairment was 18.9%. The rate of 
unilateral impairment was 10.8% and the rate of bilateral impairment was 13.5% 
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Discussion 
Several estimates have shown that the prevalence of hearing loss in the newborn 
population varies from 0.9 in 1000 to 3.24 in 1000 (51).  More than 10 infants in every 
1000 births in the developing countries are estimated to be affected by severe to 
profound hearing loss.(40)  
In India 4 out of every 1000 children born were found to have severe to profound 
hearing loss(53)(80). The National Sample Survey shows that  the prevalence of hearing 
disability per 1000 population in India was 5.53 in rural and 3.90 in urban areas(80).  
Other studies have shown various  prevalence rates from 1%, to as high as 40%.(80) 
According to Parmod Kalsotra et al congenital hearing impairment affects 1.8% of the 
population of India(57). 
Even with such high prevalence rates of hearing loss in India there is no dedicated 
national screening programme in India(57) (45).  Although ‘a universal newborn 
screening’ for early identification of hearing loss among infants had been recommended 
by the ‘National Institutes of Health Consensus Development Conference’(52),  it is yet 
to be established in India.  
Nikam and Dharamraj et al(52) attempted an infant hearing screening programme in 
1971 and  Basvaraj et al. in 1984, carried out the screening for hearing impairment in 
Bangalore. (52) 
Paul AK has initiated the screening programme in cochin in 2011.(77) 
Ideally, ABR is the method of choice for hearing screening of infants less than 5 months 
of age.  
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Hall et al. have reported in his study a specificity and sensitivity rate in excess of 96% for 
ABR screening in newborns.(73) However, due to certain drawbacks like high cost, 
difficult transportation of instrument, long execution time, and the need for qualified 
personnel to interpret the result, ABR implementation is impractical. As per the Joint 
Committee of Infant Hearing (JCIH)  recommendations the hearing assessment for the 
newborn is undertaken by screening programmes using Otoaccoustic emissions (OAE) 
and Auditory Brainstem Response audiometry (ABR) where both methods are 
automated. (73) 
Cebulla M et al, have shown that Maico MB11 BERAphone® is a reliable device for 
auditory brainstem response  screening for the newborn and in addition  it provides the 
results within a very short time.(75) It also has a high sensitivity and a low failure rate, 
and has the advantage of detecting hearing defects such as auditory neuropathy (AN).(7) 
The test is relatively quick, non-invasive and does not require sedation which makes the 
test tolerable for the babies and agreeable to parents.  It has also been recommended 
by the “American Speech –Language Hearing Association Guidelines for Audiologic 
Assessments of Children  as the method of choice for hearing screening in infants less 
than 5 months of age.(2) Therefore screening with Maico MB11 BERAphone (®) had 
been the method of choice in this study   
The average number of live babies born per month in Christian Medical College Hospital 
(CMCH) during the period of study from October2012 had been 1107. Considering the 
large numbers, implementation of the ‘universal screening programme’ in the ideal 
setting (sound treated room) was not possible; hence the screening was undertaken in 
the neonatal ward setting where the average ambient noise levels is around 62.1 dB. 
88 
 
Studies by Van Straaten HL et al also showed  that the screening test can be used in the 
ward setting without disturbance from ambient noise  and during oxygen therapy (66) 
A two stage sequential screening with BERAphone as recommended by the Joint 
committee report and which is a standard protocol of screening  in CMCH was 
performed since October 2012, to overcome the false positive results that would occur 
due to vernix and fluid present in the ears.  
The first screening was performed by well trained technicians, in the post natal ward 
where the noise conditions are typically higher than in an acoustically shielded room(Fig 
15). The results showed that out of the 37 neonates screened 23 of them were males 
and 14 were females. Statistical significance was not found between the sex ratio in 
relation to hearing loss in accordance with the study by Bener et al.(81) 
Consanguinity: Eight neonates (21.6%) under the study were born of consanguineous 
marriage and 29(78.3%) of non-consanguineous marriage. Among the 8 neonates of 
consanguineous marriage, 5 (23.3%) neonates were bilateral refer, and 3 (19.4%) 
showed bilateral pass in the second BERAphone screening. Among them only one infant 
was a confirmed case of bilateral hearing loss. There was no significant difference in the 
proportion of ‘PASS’ and ‘REFER’ among the consanguineous group of infants. From the 
29 neonates born out of non consanguineous marriage, 23 neonates (79.3%) were 
‘Referred’ and 7(24.1%) of them showed confirmed hearing loss.  
According to the study by Bener et al done in Qatar, hearing loss was more common 
among parents with first or second degree consanguinity (81). This association was not 
seen in our study probably due to the small number of infants of consanguineous 
marriage who underwent the screening. 
89 
 
With regard to parity, out of the 37(100%) neonates in the study, 17 mothers were 
primigravida and 20 were multigravida. 8 neonates of primigravida mothers showed  
‘Refer’ and 3 (17.6%) of them were confirmed with hearing loss. Among the neonates of 
multiparous mothers 19 were ‘Referred’ and 3 (15%) of them were confirmed with 
hearing loss. The association between parity and hearing loss was not significant. 
The study showed that gestational age at birth of the infants was above 36 weeks and 
hence all the neonates under the study were not preterm newborns.  
Two mothers had associated maternal risk factors. One had maternal diabetes and 
hypothyroidism and underwent delivery by Caesarean section. Another mother had 
maternal diabetes. Neonates of both the mothers with risk factors showed confirmed 
hearing loss.  
A study by Ohl C, et al on newborn hearing screening showed that association of several 
risk factors could be a significant additional risk factor for hearing impairment.(82) 
Our study show 100% association with the maternal risk factor diabetes , however our 
sample size is too small (i.e. 2 mothers only) to consider the association significant. 
Table 7 shows various perinatal variables assessed in the study.  Of the 3 neonates with 
birth weight <2.5kg, all 3 showed confirmed hearing loss.  Ohl C, et al in their study also 
showed that birth weight less than 1500g and premature birth before the 34th week of 
pregnancy did not show a statistically significant association with sensorineural hearing 
loss. (82) There were 12 neonates born of LSCS. Of these 9 neonates were ‘referred’; 
among them 4 neonates had confirmed hearing loss and rest of the 8 showed normal 
hearing.  
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Bener et al (81)showed in his study that family history of hearing loss and other risk 
factors like, prenatal smoking, prenatal high blood pressure and caesarean section did 
not show any significant association with neonatal hearing loss. (81) 
Among the other risk factors two had neonatal jaundice, one had seizure and one infant 
had bacterial infection. From these, 3 were ‘Referred’, but only one had confirmed 
hearing loss. 
Sanders et al showed that 2 to 4% of neonates with one or more risk factors such as 
birth asphyxia, hyperbilirubinemia, prolonged NICU stay, low birth weight, in-utero 
TORCH infections etc. exhibit a moderate to profound hearing loss. (83)(84)  
A  Study by Hille ET et a(85)revealed that severe birth asphyxia was the only 
independent risk factors for hearing loss seen in their study.(85) 
Many authors suggest that ‘hereditary’ causes approximately one half of sensorineural 
hearing loss in children (86)(44). Similarly, one study showed that more than 50 percent 
of hearing impairment in children is genetic in origin and was unrelated to non-inherited 
causes, infections and anatomic abnormality [6].  
In our study only normal infants were recruited ( infants with congenital anomalies were 
excluded). While craniofacial anomalies (mostly cleft palate and ear aplasia) were a 
significant factor for conductive hearing loss(82), such infants were not included  in our 
study. 
In our study we followed a two step protocol for screening. The first screening sample 
included a total of 37 infants who have been referred once which made up to a sample 
size of 74 ears.  All the infants were subjected to the second BERAphone screening. 
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Clemens et al. (75) had published the results of a survey investigating this issue where all 
the infants were subjected to the second screening. (75) The main goal is to decrease 
the false-positive results of the first screening so that stress caused by a referral for 
further testing to the parents is minimized. This in turn will reduce the costs incurred by 
the second stage screening and further diagnostic tests. 
Mario Cebulla et al (75) showed in their study that the pass rate in the first stage of the 
hearing screening performed at the well-baby nursery was 96.2%(75). 
A two step protocol had been followed which was similar to many studies. Benito-Orejas 
JI, et al(87),  followed a two step screening protocol where the first screening was 
undertaken during the first 48 hours of life, before discharge from the hospital and the 
infants referred from the first screening underwent a second screening after discharge, 
before one month .  
They showed that aABR gave 2.6% failed results in the first screening and  in the second 
screening step, 0.32% of those screened with aABR were referred.(87)  
Another study by Lin HC et al (88)showed a significant reduction in referral rate using a 
two step protocol. The referral rate of 5.8% in the first screening came down to 1.8% in 
the second screening. The rate of congenital hearing loss in the 1 step protocol was 
0.45% and 0.3% in the 2 step protocol (88) 
Another study by Iley KL et al (89)concluded that the adoption of aABR as an initial 
screening is less expensive ,more practical, and  acceptable to the parents.(89) 
The second screening of infants who have been ‘referred’ in the first screening was done 
after a period of one week in a sound treated room in the department of Audiology with 
an ambient sound level of 44 dB. We have adopted this approach of performing the 
92 
 
second screening after a week since an earlier study shows a large number of drop outs 
when there was a delay in the second screening. 
Mathur et al (90)suggests that screening all neonates within the first 48 hours of life is 
impractical and that it should be delayed upto three months of age(90). However in our 
study the second screening could be completed as per the protocol. 
Of the 74 ears of newborns referred for the second stage screening, 31(41.9%) ears 
passed and 43 (58.1%) ears were referred again. Therefore the pass rate for the second 
screening was 41.9 % and the referral rate was 58.1 % (Fig 23). According to study by 
Mario Cebulla et al second stage hearing screening in the Department of Audiology 
showed that 27.4% passed  and 72.6% referred again. (75)  
Our study showed one neonate with a false negative result (7.1%) and 15 neonates had 
false positive results (50%) which is high compared to various studies. Stewart DL 
(91)showed that the refer rate using universal hearing screening with the aABR was 
acceptably low < 2% and  the false-positive rate was between  0.3% to 2.5% although it 
was performed by various personnel and  the total incidence of confirmed SNHL was 2.7 
per thousand newborns.(91) 
Another study done by Lin HC et al(92) showed that screening with BERAphone  reduced 
the number of  false positives where the rate of congenital hearing loss was 0.42% in 
aABR protocol(92). Thus using screening tools like BERAphone helped in the reduction of 
false positives. Our study showed 50% of false positives. 
All the infants who underwent the second screening were subjected to the confirmation 
test by ABR which enabled the assessment of the sensitivity (True positive) and 
specificity (True negative) of the test.  
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ABR Confirmation 
On confirmatory testing by ABR, of the 74 ears tested, 14 ears (18.9%) had confirmed 
hearing loss and 60 ears (81.1%) were normal which represents a percentage of 
confirmed hearing loss of 18.9% and a pass level of 81.1%. (Fig 25). 
ABR confirmation showed that of the 9 neonates with hearing loss, 5 neonates had 
bilateral impairment and 4 neonates had a unilateral impairment. The remaining 28 
newborns were found to have bilaterally normal hearing. 
The MB11 test yielded 1 false negative(7.1%) and 30 false positives(50%). As per the 
study the Efficacy of MB11 showed  
Sensitivity of - 92.9% (95% CI: 66.06 % to 98.81 % )  
Specificity of - 50% (95% CI: 36.81 % to 63.19 % ) 
The positive predictive value was 30.23 % %( 95% CI: 17.20 % to 46.13 % ) and negative 
predictive value was 96.77%  (95% CI: 83.24 % to 99.46 %) for the diagnosis of hearing 
loss. 
Confirmed Hearing loss 
From our study the observed prevalence of confirmed hearing impairment was 18.9%. 
The rate of unilateral impairment was 10.8% and the rate of bilateral impairment was 
13.5%. All the 9 infants with confirmed hearing loss have been put on regular follow up. 
Our study confirms the manufacturer’s claim that the test has a sensitivity greater than 
0.96.(7) but does not correspond to the claimed specificity of greater than 0.99.  
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Several studies have been reported with the use of BERAphone® as a screening devise. 
Van Straaten et al. reported a 92% pass and 98% pass after the after the first and second 
screening using automated ABR (66) 
A study of comparison of currently available newborn hearing screening devices in 2004 
by Meier S et al(76) showed that pass rates were highest (98%) for aABR recordings 
using the Algo 3 and lowest (92%) for aABR recordings using the Beraphone MB11, 
although there was no statistically significance in the differences among them.(76) A 
study by Melagrana A et al (79)of newborns who were evaluated after the second 
month of life showed that the MB11 test had no false negatives but had yielded 10 false 
positives .  
The MB11 test showed a good specificity of 96.8% (95% CI 94.8-98.7%) and a sensitivity 
of 100% (95% CI 93.9-100%). The positive predictive value was 88.2% (95% CI 79-93.9%) 
and a negative predictive value was 100% (95% CI 98.4-100%) for diagnosis of hearing 
loss.(79)  
However our results showed a sensitivity of - 92.9% (95% CI: 66.06 % to 98.81 % ), 
specificity of - 50% (95% CI: 36.81 % to 63.19 %), positive predictive value of 30.23 % ( 
95% CI: 17.20 % to 46.13 % ) and negative predictive value of 96.77 %  (95% CI: 83.24 % 
to 99.46 %) for the diagnosis of hearing loss using the MB11 BERAphone in the postnatal 
ward setting.  
Although studies have been done using different screening protocols under quiet 
conditions, few studies have been reported from developing countries where the 
screening tool is used in the ward setting due to high volume of deliveries.  This makes 
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our study unique because this testing was performed in the ward in the presence of 
ambient noise.  
One study by Richmond et al(93) has indicated that ambient noise levels can cause 
alteration in the screening results of the infants.(93) Therefore this study would provide 
an index for future screening in such environment. 
Our study shows a higher prevalence of hearing loss than that reported in the literature. 
This value is seen after the confirmation with the gold standard screening with ABR. The 
reason for the high prevalence can be attributed to the fact that only newborns who 
were ‘referred’ on the first screening were recruited for the study.  
Bansal et al (94) in his study suggested a delayed hearing screening at 3 months of age 
which would  bring down the number of false positive cases  and that the 
implementation of the universal neonatal hearing screening within 48h of life was 
impractical for developing countries. He also suggested in the study that the screening 
be combined  with 3rd dose of universal immunization program which can be 
incorporated into national deafness programs in the developing countries.(94) Olusanya  
et al in their study also suggests that in developing countries hearing screening programs 
are practical if integrated into childhood immunization programs.(95) While screening 
the infants along with the immunization programme in a novel approach in developing 
countries, delay of the screening to 3 months would miss out on early identification and 
rehabilitation. 
Good screening tests have high sensitivity and the two stage screening with BERAphone 
has shown high sensitivity. Those tests with very high sensitivity are useful “to rule out” 
diseases or characteristics if they come back negative.  On the other hand good 
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confirmatory tests have high specificity and two stage screening with BERAphone has 
shown a low specificity.  High specificity is useful “to rule in” diseases or characteristics if 
they come back positive. Both sensitivity and specificity are intrinsic properties of a 
given test which do not depend on the given population. Positive and negative 
predictive values however are dependent on the prevalence rate of the characteristic in 
a given population.  The rarer the characteristic, the lower the positive predictive value 
and the higher the negative predictive value. The two stage screening protocol with 
BERAphone has a low positive predictive value and a high negative predictive value. The 
prevalence of hearing loss in the study group (13/74) was 18.9%. The BERAphone would 
have had a higher positive predictive value had the prevalence been higher i.e in a 
situation with a higher prevalence (eg NICU). In such situations BERAphone would be a 
useful screening tool. A third round of screening with BERAphone may have improved 
the predictive value of this instrument and this would have to be the subject of a future 
study. 
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Summary 
Hearing loss is a silent crippling sensory disorder of childhood. If left undiagnosed it can 
result in speech, hearing and communication problems. Early detection through 
screening as recommended in the universal screening protocol is mandatory. 
The present study was done to evaluate the effectiveness of the screening tool 
BERAphone when it is used to screen high volumes of babies in the natural ward setting 
with background noise. Our study had used the updated version of the MB 11 device 
which is known to increase the amplitude of the ABR response using a chirp stimulus. 
These studies were carried out on healthy newborns who did not present with any 
particular audiologic risk factors within the first days of life.   
The present report shows the data analysis from 37 newborns screened using the MB11 
BERAphone® as a screening tool. The first stage of the two staged hearing screening was 
performed in the postnatal ward and the second stage in the audiology lab. After the 
two stage screening the pass rate was 41.9% and the referral rate was 58.1%. The 
screening tool BERAphone showed a sensitivity of 92.86%, a specificity of 50%, positive 
predictive value of 30.23 % and negative predictive value 96.77% for the diagnosis of 
hearing loss. 
The results that were obtained show that MB11 is a good screening tool among infants 
and can be used as a first level diagnostic tool for suspected hearing loss but must be 
verified with Auditory Brainstem Response (ABR) which is the “gold standard” test 
essential to a correct neonatal screening programme.  
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Conclusion 
From our experience, the MB11 BERAphone® is a reliable device for use in a two stage 
newborn hearing screening based on auditory brainstem response. It gives good results 
within a very short time with minimal cost of materials since no disposables are 
necessary to be used compared to other ABR screening devices. Due to the 
implemented automated detection algorithm for ABR, the device is suitable for use by 
trained technicians in a post natal environment. 
The machine shows good specificity as predicted where it is able to identify those who 
do not have the disease but it has a low sensitivity than expected when used in the ward 
setting with surrounding high ambient noise.  Thus it must be used along with a 
confirmatory test like ABR to establish hearing loss.  
Disclaimer: 
The investigators declare that the study was performed independently and neither the 
authors nor the department have received any monetary support in any form from any 
industry or other external source related to the material discussed in this manuscript.  
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PARENTS INFORMED CONSENT FORM TO PARTICIPATE IN A RESEARCH STUDY 
Study Title: SENSITIVITY AND SPECIFICITY OF BERAPHONE® AS A SCREENING TOOL FOR     
                          NEONATAL HEARING LOSS IN A TERTIARY CARE HOSPITAL IN INDIA 
Study Number:8052 
Hospital No: 
Subject’s Name: _______________________ Mother’s name_____________________ 
Date of Birth / Age:_______ 
I the mother /close relative confirm that I have read and understood the information 
sheet dated _________ for the above study and have had the opportunity to ask 
questions. [    ] 
(ii)I have been informed that the Neonatal Hearing Screening is done for all the babies 
born in CMCH. Hence the current research involves testing the babies for hearing 
problems from the time of birth. I am aware that my baby may be enrolled in the 2 step 
hearing screening. 
(iii) I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care or legal rights 
being affected. [    ] 
 (iv) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission 
to look at my health records both in respect of the current study and any further 
research that may be conducted in relation to it, even if I withdraw from the trial. I agree 
to this access. However, I understand that my baby’s identity will not be revealed in any 
information released to third parties or published. [    ] 
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(v) I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s) [    ] 
(vi) I agree to take part in the above study. [    ] 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______        
Name of the Witness: _____________________________ 
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PATIENT INFORMATION SHEET 
Hearing is a special ability that develops in the womb before the child is born. After birth 
the child develops speech and language in the first 3 years of life which is very important 
for the development of communication, and educational skills. 
It is estimated that 4 out of every 1000 children born in India have hearing loss in spite 
of the parents having no hearing problems. Unless the hearing loss is detected early and 
appropriately treated by the age of one year, the child may develop speech and 
language defects which in turn can limit communication and learning. 
Screening of newborn babies for hearing impairment is done routinely at an early age in 
many parts of the world in order to detect hearing loss and initiate appropriate 
rehabilitation.  
In CMCH hearing screening is being carried out for all babies born in the hospital for the 
past two years. The test is done using an instrument called ‘BERAphone’. 
The first test is done within 1-2 days after the delivery. During the test, the earphones of 
the machine are placed over your child’s ear at the bed side. The instrument produces a 
series of soft click sounds and records the response to these sounds from the brain. 
After analysing these responses the machine produce a ‘pass’ result if the hearing is 
normal or a ‘refer’ result if there is a suspicion of hearing loss.  
For babies who obtain a ‘refer’ result on the first screening test, a second screening will 
be done after one week in the audiology lab and those babies will be examined by an 
ENT specialist’ on the same day.  Following  this certain specialized tests called 
‘Tympanometry’ (to find out about the condition of the middle ear) and a reliable 
standard hearing test called ABR is done to confirm the results of the previous screening 
tests. If hearing loss is present after the second testing the babies are booked in the 
‘Audiovestibular clinic’ where evaluation and appropriate methods for rehabilitation will 
be suggested. 
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These tests done on your baby will not cause any pain, reaction or harm. The test will 
have the best results when the child is sleeping after feeds 
During the course of this routine testing a special study is being done to find out the 
accuracy of the machine (BERAphone) which is used for screening new born babies. 
There are no risks involved in this study. You will not have to bear any additional costs as 
a result of enrolling in the study apart from the cost of routine tests. . 
Your participation in this study is purely voluntary and you can withdraw from this study 
at any time you feel so. This will not compromise your treatment at ENT department. 
Your participation in the study will remain confidential and the results of the tests 
conducted on your baby will not be disclosed to others. For any queries you can contact: 
Dr Chavakula Rajkumar 
PG Registrar 
Dept. of ENT, 
CMC Vellore, Mob: 08344041008 
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Proforma for Neonatal Hearing Screening 
Mother’s Name______________ Mo.Hosp.No _____________ 
Baby’s Hosp No.__________ 
FAMILY HISTORY  
Consanguinity:        Yes No  
S. No Age Sex About 
child 
Educational 
level 
Present 
occupation 
Special 
needs 
Illnesses 
 
 
 
       
H /o Speech delay, Hearing insufficiency, Visual insufficiency, poor scholastic performance in : 
    
i. Father ii. Paternal grandparents iii. Siblings 
iv. Mother v. Maternal grandparents vi. Others  Yes No  Dk 
Neurofibromatosis     Yes No  Dk 
White forelock     Yes No  Dk 
Blindness      Yes No  Dk 
Cardiac diseases     Yes No  Dk 
Specify: 
Renal disease      Yes No  Dk 
Short neck      Yes No  Dk 
Other disease      Yes No  Dk 
Specify:  
ANTENATAL HISTORY  
TORCHES/HIV Infection  at         
_________ months of  pregnancy    
              Yes No  
 1-3 4-7 8-10 (encircle) 
(fever with rash + joint pains + lymphnode enlargement) 
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H/o Diabetes      Yes No   
H/o  Hypothyroidism     Yes No   
H/o ototoxic drug (aminoglycosides, frusemide)  
usage by mother for > 3 days during pregnancy Yes No  Dk 
H/o Other illness     Yes No  Dk 
Specify: 
PERINATAL HISTORY 
Date of Birth ___/___/_____    Date of Examination___/___/_____ 
 Birth Weight _____________  gm   Gest Age: ___________ weeks 
Sex: Male / Female      
APGAR: 1’_____ 5’______10’_____ 
(1) Labour > 24 hours      Yes No 
 (2) Neonatal Asph yxia      Yes No  
Respiratory distress     Yes No 
Meconium aspiration     Yes No  
(5) Neonatal bacterial infections    Yes No  
 (6) Meningitis      Yes No 
(7) Hyperbilirubinemia     Yes No  
(8) Seizures      Yes No  
(9) SGA/?Suspected TORCH   Yes No 
(Check for IgM test on the patient order sheet)    
(10) Ventilatory support > 48 hours   Yes No 
(11) Ototoxic medication (gentamycin, frusamide)  Yes No  
(12) Exchange transfusion     Yes No  
Dysmorphic features (please describe if any) 
Face 
Trunk 
Limbs 
Genitalia 
Skin                                                               Other 
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COLOUR PLATES 
 
Colour plate1: ABR report with normal hearing 
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        Colour plate 2:: ABR report with Bilateral hearing los 
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Colour plate 3: BERAphone unit 
 
Colour plate 4right ear ‘Pass’ result with BERAphone 
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Colour plate 6: Right ear ‘Refer result’ with BERAphone 
 
Colour plate8: Left Ear ‘Pass’ Result with BERAphone 
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Colour plate 8: Left ear ‘Refer’ result with BERAphone 
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DATA SHEET - 1 
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DATA SHEET - 2 
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DATA SHEET - 3 
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DATA SHEET - 4 
 
 
sno place con cage csex cdob cbwight cascore1 cascore5 dbp1 rdbp1 ldbp1 dbp2 rdbp2 ldbp2
1 Vellore 1 new born 2 10/7/2012 2.53 9 10 10/8/2012 ref-25% ref 10/16/2012 ref-25% ref
2 vellore 0 new born 1 10/12/2012 3.48 9 10 11/13/2012 ref ref 11/7/2012 ref ref
3 Vellore 1  new born 1 10/9/2012 2.1 9 10 10/10/2012 ref pass 11/5/2012 pass pass
4 Chittor 0 new born 2 10/4/2012 3.52 9 10 12/5/2012 pass ref 11/7/2012 ref ref
5 Chennai 0 new born 2 2/13/2013 2.54 9 10 2/14/2013 pass ref 3/6/2013 ref pass
6 Vellore 0 new born 1 1/10/2013 2.64 9 10 1/11/2013 ref pass 1/31/2013 pass pass
7 Vellore 0 new born 1 2/14/2013 3.19 9 10 2/15/2013 ref ref 3/14/2013 ref pass
8 Vellore 0 new born 2 3/1/2013 3.4 7 9 3/3/2013 pass ref 3/20/2013 ref ref
9 Meghalaya 0 new born 1 1/9/2013 2.9 9 9 1/10/2013 ref pass 1/23/2013 pass pass
10 Vellore 0 new born 2 3/31/2013 2.87 9 9 4/1/2013 ref ref 4/4/2013 ref ref
11 Arni 0 new born 1 4/1/2013 3.09 9 9 4/2/2013 ref pass 4/8/2013 pass pass
12 Thrichurap 0 new born 1 4/1/2013 2.86 9 9 4/2/2013 ref ref 4/10/2013 ref ref
13 Vellore 0 new born 1 4/3/2013 2.76 9 9 4/4/2013 pass ref 4/16/2013 ref pass
14 Thiruvanam 1 new born 1 4/7/2013 3.4 9 10 4/11/2013 ref ref 4/16/2013 ref ref
15 velore 0 new born 2 4/8/2013 2.78 9 10 4/9/2013 pass ref 4/19/2013 ref pass
16 Velore 0 new born 1 4/8/2013 3.3 9 10 4/9/2013 pass ref 4/22/2013 ref pass
17 Vellore 0 new born 1 4/11/2013 2.77 7 9 4/12/2013 ref ref 4/25/2013 ref pass
18 Tiruvamlai 0 New born 2 4/10/2013 3.05 9 9 4/11/2013 ref pass 4/26/2013 pass pass
19 Chitoor 1 new born 2 4/9/2013 2.79 9 10 4/11/2013 ref pass 4/30/2013 pass pass
20 Vellore 0 new born 2 1/8/2003 3.4 9 9 4/9/2013 pass ref 5/1/2013 ref ref
21 Vellore 0 new born 2 4/24/2013 2.82 9 9 4/25/2013 pass ref 5/2/2013 ref pass
22 Vellore 1 new born 2 4/4/2013 3.28 9 10 4/11/2013 ref pass 4/25/2013 pass pass
23 Vellore 0 new bor 1 5/8/2013 3.02 9 10 5/9/2013 pass ref 5/20/2013 ref pass
24 vellore 0 new born 2 5/8/2013 3.06 6 10 5/9/2013 ref ref 5/22/2013 ref ref
25 polur 0 new born 1 5/26/2013 2.84 9 10 5/27/2013 ref pass 6/3/2013 pass pass
26 Thiruvalam 0 new born 1 5/15/2013 2.8 9 9 5/17/2013 ref pass 6/3/2013 pass pass
27 Thiruvamal 0 new born 1 6/2/2013 2.92 9 10 6/3/2013 pass ref 6/7/2013 ref pass
28 vellore 1 new bor 1 6/8/2013 2.08 9 9 6/10/2013 ref ref 6/19/2013 ref ref
29 chittor 0 new born 1 7/3/2013 3.18 9 9 7/4/2013 pass ref 7/11/2013 ref ref
30 Thiruvamal 0 new born 1 8/29/2013 3.14 9 9 8/31/2013 ref ref 9/6/2013 ref ref
31 velore 1 new born 1 9/1/2013 2.57 5 9 9/3/2013 ref ref 9/13/2013 ref ref
32 vellore 1 new born 1 9/11/2013 2.66 9 10 9/12/2013 ref pass 9/16/2013 ref ref
33 vellore 0 new born 1 9/3/2013 2.03 2 9 9/6/2013 ref pass 9/13/2013 ref pass
34 vellore 0 new born 1 9/17/2013 2.88 9 10 9/19/2013 pass ref 10/2/2013 pass referred
35 Bangalore 0 new born 2 10/17/2013 2.86 9 10 10/19/2013 ref pass 10/21/2013 ref pass
36 vellore 0 new born 2 6/26/2013 2.67 9 10 6/27/2013 ref ref 10/3/2013 ref ref
37 Vellore 0 new born 1 10/19/2013 3.58 9 10 10/22/2013 ref ref 11/1/2013 pass ref
sno dabr rabr labr clabor cna crd cbi cm cj cs ct cv com cet ceexam cnexam ctexam cgexam cgexam1 sno
1 11/1/2012 pass pass 0 0 0 0 0 1 0 0 1 0 0 normal normal normal normal normal 1
2 11/7/2012 ref ref 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 2
3 11/5/2012 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 3
4 11/7/2012 pass Ref 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 4
5 3/6/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 5
6 1/31/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 6
7 3/14/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal norma normal 7
8 3/20/2013 pass pass 0 0 0 0 0 0 1 0 0 0 0 normal normal normal normal normal 8
9 1/23/2013 pass pass 0 0 0 1 0 0 0 0 0 0 0 normal normal normal normal normal 9
10 4/4/2013 pass ref 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 10
11 4/8/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 11
12 4/10/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 12
13 4/16/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 13
14 4/16/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 14
15 4/19/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 15
16 4/22/2013 pass pas 0 0 0 0 0 0 0 0 0 0 0 normal normalnorm al normal normal 16
17 4/25/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 17
18 4/26/2013 pas pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 18
19 4/30/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 19
20 5/1/2013 pas pass 0 0 0 0 0 0 0 0 0 0 0 Normal normal normal normal normal 20
21 5/2/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 21
22 4/25/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 22
23 5/20/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 Normal noral normal normal normal 23
24 5/22/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 noral normal normal normal normal 24
25 6/3/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 25
26 6/3/2013 pas pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 26
27 6/7/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 27
28 6/19/2013 pas pass 0 0 0 0 0 0 0 0 0 0 0 normal normalnorm al normal normal 28
29 7/18/2013 normal normal 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 29
30 9/16/2013 ref ref 0 0 0 0 0 0 0 0 0 0 0 normal normal normal noral normal 30
31 10/16/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 31
32 9/20/2013 ref ref 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 32
33 9/13/2013 ref ref 0 0 0 0 0 1 0 0 0 0 0 normal normal normal normal normal 33
34 10/2/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 34
35 10/21/2013 pass pass 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 35
36 10/3/2013 ref ref 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 36
37 11/1/2013 pass refer 0 0 0 0 0 0 0 0 0 0 0 normal normal normal normal normal 37
cgexam2 cgexam3 cgexam4 cgexam5 fshsd fhd fhb nf wf hd kd sn od fsex fage fed fo msex mage
normal normal normal clubfoot 0 0 0 0 0 0 0 0 nil 1 2 25
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 2
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 23 9th std coolie 2 21
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 28 12th std business 2 26
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 33 MBA Accounts 2 31
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 27 B.E officer 2 25
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 32 12th std coolie 2 31
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 28 BA company 2 27
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 27 10th std labourer 2 23
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 29 12th std police 2 20
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 8th sd textile 2 18
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 2 20
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 2 29
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 34 Mcm Student 2 31
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 2 25
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 30 10th std farmer 2 25
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 25 BBA Business 2 24
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 29 Polytech college 2 27
normal normal nomal nil 0 0 0 0 0 0 0 0 nil 1 32 MBA Software 2 25
normal nrmal normal nil 0 0 0 0 0 0 0 0 nil 1 10thbu std business 2 23
normal normal normal nil 0 0 0 0 0 0 0 0 nl 1 36 12th std electrical 2 34
normal normal normal il 0 0 0 0 0 0 0 0 nil 1 45 10th std vet 2 33
normal ormal normal nil 0 0 0 0 0 0 0 0 nil 1 36 MBA Business 2 31
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 2 23
normal normal normal normal 0 0 0 0 0 0 0 0 nil 1 2 31
normal normal norml nil 0 0 0 0 0 0 0 0 nil 1 41 ITI Superisor 2 39
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 2 24
normal normal normal nil 0 0 0 0 0 0 0 0 nil 1 30 5th std shop 2 27
normal normal normal noral 0 0 0 0 0 0 0 0 no 1 2 28
normal normal normal normal 0 0 0 0 0 0 0 0 nil 1 2 29
normal normal normal normal 0 0 0 0 0 0 0 0 nil 1 2
normal normal normal normal 0 0 0 0 0 0 0 0 nil 1 2 23
normal normal normal normal 0 0 0 0 0 0 0 0 nil 1 2 21
normal normal normal normal 0 0 0 0 0 0 0 0 nil 1 2
normal noemal normal normal 0 0 0 0 0 0 0 0 nil 1 2 26
normal normal normal normal 0 0 0 0 0 0 0 0 nil 1 2
ormal normal normal normal 0 0 0 0 0 0 0 0 nill 1 2 27
sno med mo gage para del mt md mt1 mod moi
1 house wife 40.3 G-2, A-1 LSCS 0 0 0 0 0
2 house wife 39.2 primi NVD 0 0 0 0 0
3 7th std House Wife 37.2 primi NVD 0 0 0 0 0
4 12th std housewife 41.4w primi LSCS 0 1 1 0 0
5 PECE house wife 40.5w primi NVD 0 0 0 0 0
6 B.Tech Infosys 37.6 primi LSCS 0 0 0 0 0
7 12th std house wife 39.3 P2,L2,A2 NVD 0 0 0 0 0
8 BSc Nurse Nurse 39.6 primi NVD 0 0 0 0 0
9 ANM Aux nurse 37.5 pimi LSCS 0 0 0 0 0
10 12th std house wife 39.3 primi vaccum cup 0 0 0 0 0
11 10th std house wife 39.4 primi NVD 0 0 0 0 0
12 house wife 39.6 primi NVD 0 0 0 0 0
13 house wife 36.5 p-1,L-1 NVD 0 0 0 0 0
14 MSc Student 39.3 G2,A1 NVD 0 0 0 0 0
15 house wife 39 G2,A1 NVD 0 0 0 0 0
16 DTA Teacher 38.5w G2,P1,L1 NVD 0 0 0 0 0
17 BCom House wif 39.2 Primi NVD 0 0 0 0 0
18 BCom Bank 39.6 primi Suction cup 0 0 0 0 0
19 MCA House wife 38.6 primi NVD 0 0 0 0 0
20 10th std house wife 40.4 G5,P2,L2A2 NVD 0 0 0 0 0
21 12th std house wife 36.2 G5P2,l2,a2 LSCS 0 0 0 0 0
22 12th std house wife 39.6 G2,P1,L1 NVD 0 0 0 0 0
23 MABEd Teacher 37.6 G2,p0,loA1 NVD 0 0 0 0 0
24 Housewife 38.3 G4,P1,L1A2 LSCS 0 0 0 0 0
25 House wife 39w G2,P1,L1 NVD 0 0 0 0 0
26 BSc House wife 38.3 G2,P1,L1 LSCS 0 0 0 0 0
27 house wife 38.5 G2,A1 NVD 0 0 0 0 0
28 10th std house wife 36.2 G2P1L1 LSCS 0 0 0 0 0
29 house wife 38.6 G2P1L1 LSCS 0 0 0 0 0
30 house wife 36.6 G2P1L1 LSCS 0 0 0 0 0
31 40.6 G2p1A1 suction cup 0 0 0 0 0
32 38 G1p1 NVD 0 1 0 0 0
33 house wife 36.2 primi LSCS 0 0 0 0 0
34 38.6 p2l2 NVD 0 0 0 0 0
35 40 p2l2 NVD 0 0 0 0 0
36 39.5 G2p1L1 NVD 0 0 0 0 0
37 37.4 G2,P-1,L-1 LSCS 0 0 0 0 0
